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ABSTRACT OF DISSERTATION

IDENTIFICATION AND CHARACTERIZATION OF COMPONENTS OF
THE YEAST SPLICEOSOME

The spliceosome is a complex, dynamic ribonucleoprotein (RNP) complex
that undergoes numerous conformational changes during its assembly,
activation, catalysis and disassembly. Defects in spliceosome assembly are
thought to trigger active dissociation of faulty splicing complexes. A yeast genetic
screen was performed to identify components of the putative discard pathway.
This study found that weak mutant alleles of SPP382 suppress defects in
several proteins required for spliceosome activation (Prp38p, Prp8p and Prp19p)
as well as substrate mutations (weak branch point mutants). This evolutionary
conserved protein had been found in both yeast and mammalian splicing
complexes. However, its role in splicing had not been elucidated. This study
focused on understanding the cellular role of Spp382p in splicing and particularly
in the discard pathway. Spp382p was found to be essential for normal splicing
and for efficient intron turnover. Since Spp382p binds Prp43p and is required for
intron release in vitro, spp382 mediated suppression of splicing factor mutations
might reflect lowered Prp43p activity. In agreement with this, we find that prp43
mutants also act as suppressors. This leads us to propose a model in which
defects in spliceosome assembly, like those caused by prp38-1, prompt
Spp382p-mediated disassembly of the defective complex via Prp43p Bolstering
this theory, we find that Spp382p is specifically recruited to defective complexes
lacking the 5’ exon cleavage intermediate and spp382 mutants suppress other
splicing defects.
I show by stringent proteomic and two-hybrid analyses that Spp382p
interacts with Cwc23p, a DnaJ-like protein present in the spliceosome and copurified the Prp43p-DExD/H-box protein. In this study, I also show that Cwc23p is
itself essential for splicing and normal intron turnover. Enhanced expression of
another protein, Sqs1p, structurally related to Spp382p and also found
associated with Prp43p is inhibitory to both growth and splicing. Synthetic lethal
and dosage suppression studies bolster a functional linkage between Spp382p,
Cwc23p, Sqs1p and Prp43p and together, the data support the existence of a

Spp382p -dependent spliceosome integrity (SPIN) complex acting to remove
defective spliceosomes.

Key Words – pre-mRNA, Splicing, Spp382, Discard Pathway, Spliceosome

Shatakshi Shreekant Pandit

September 4, 2007

IDENTIFICATION AND CHARACTERIZATION OF COMPONENTS OF
THE YEAST SPLICEOSOME

By
Shatakshi Shreekant Pandit

Dr. Brian C. Rymond
Director of Dissertation

Dr. Brian C. Rymond
Director of Graduate Studies
September 05, 2007

RULES FOR THE USE OF DISSERTATIONS
Unpublished dissertations submitted for the Doctor's degree and
deposited in the University of Kentucky Library are as a rule open for
inspection, but are to be used only with due regard to the rights of the
authors.
Bibliographical references may be noted, but quotations or summaries of
parts may be published only with the permission of the author, and with
theusual scholarly acknowledgments.
Extensive copying or publication of the dissertation in whole or in part also
requires the consent of the Dean of the Graduate School of the University
of Kentucky.
A library that borrows this dissertation for use by its patrons is expected to
secure the signature of each user.

DISSERTATION

Shatakshi Shreekant Pandit

The Graduate School
University of Kentucky
2007

IDENTIFICATION AND CHARACTERIZATION OF COMPONENTS OF
THE YEAST SPLICEOSOME

__________________________________________
DISSERTATION
__________________________________________
A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy in the
College of Arts and Sciences at the
University of Kentucky

By
Shatakshi Shreekant Pandit
Lexington, Kentucky
Director: Dr. Brian C Rymond
Lexington, Kentucky
2007
Copyright © Shatakshi Shreekant Pandit 2007

ACKNOWLEDGEMENTS
This dissertation would not have been possible but for the love and
support shown by numerous people and I am grateful to every one of
them.
First and foremost, I have to thank my family for their
encouragement and understanding throughout this process, especially my
parents who have put up with my non-existent vacations and have
supported my decision to do grad school throughout. And special thanks
to Shailesh and Rta for knowing just what to say to make me keep going
and their immeasurable support through out the process.
I would like to thank my advisor, Brian C Rymond, for his guidance,
wisdom and patience through out the process. Without him, my skills and
knowledge of this field would not be possible. Also, thanks to my
committee members, Drs. Peterson, Kellum and Mirabito who were willing
to give their time to help guide me to the completion of this dissertation. I
am grateful to other faculty members in the Department of Biology who
have always lend a helping hand in the form of advice or expertise which
made my graduate life less stressful.
I must acknowledge past lab members of Rymond lab, especially
Dr. Qiang Wang and Kevin Vincent, who were always available for advice
and guidance for which I am indebted to. Special thanks to MingXia and

iii

other lab members, graduate and undergraduates, who have helped me
during this dissertation.
And finally thanks to all the graduate students and friends in the
biology program. Especially, Andy, Sameera, Mohati, Sonya and Scott
Frasure, who have always been there to encourage and support me and
helped to keep my sanity in check.

iv

TABLE OF CONTENTS

IDENTIFICATION AND CHARACTERIZATION OF COMPONENTS OF THE
YEAST SPLICEOSOME
ABSTRACT OF DISSERTATION
ACKNOWLEDGEMENTS……………………………………………………………..III
TABLE OF CONTENTS………………………………………………………………..V
LIST OF TABLES……………………………………………………………………..VIII
LIST OF FIGURES…………………………………………………………………….IX
LIST OF FILES…………………………………………………………………………XI

CHAPTER 1: INTRODUCTION……………………………………………………….1
Splicing and the Spliceosome- An overview………………….………...1
Chemistry of Splicing…………………………………………………………......3
Sequence requirements………………………………………………………….3
DExD/H-box Proteins in Splicing………………………………………………..5
Spliceosome Assembly and DExD/H proteins……………………….…..6
DExD/H box protein involvement in post-assembly events……….…..13
Disassembly and DExD/H box proteins…………………………………14
Fidelity and DExD/H box helicase…………………………………….….15
CHAPTER 2: MATERIALS AND METHODS……………………………………….18
Yeast genetics and plasmid construction……………………………………..18
Yeast Strains………………………………………………………………...18
Microbial Methods………………………………………………………………..21
E.coli Methods………………………………………………………………..21
Yeast Methods
…………………………………………………..21
Yeast Suppressor Screen …………………………………………………23
Mutagenesis …………………………………………………………………..25

v

RNA Methods.…………………………………………………………………......26
Northern Analysis: …………………………………………………………….26
Primer Extension Analysis……………………………………………………27
In Vitro Splicing Assay and Spliceosome Assembly: ………………………27
Co-immunoprecipitation of snRNAs: ……………………………………….27
SnRNP analysis ………………………………………………………………28
Protein Purification and Mass Analysis. ……………………………………….28
In vivo labeling and TAP purifications ………………………………………29
Western blotting ……………………………………………………………….29
Spp382p depletion…………………………………………………………….30
Primer List For Spp382: …………………………………………………………31
Primer List For The Rest: ……………………………………………………….32
Site Directed Mutagenesis Primer List: ………………………………………33
List of splicing factors used for over expression.……………………………..34
CHAPTER 3: RESULTS ………………………………………………………………36
Identifying extragenic suppressors of the prp38-1 spliceosome maturation
mutant. ………………………………………………………………………………….36
Reduced Spp382p activity suppresses the prp38-1 defect. …………………41
Spp382p is required for splicing and for normal intron metabolism. ………..53
Extracts from yeast depleted of Spp382p fail to assembly complete
spliceosomes. ………………………………………………………………………….64
Spp382p is not an integral snRNP protein but its depletion inhibits stable trisnRNP formation in vivo.……………………………………………………………...67
Spp382p binds spliceosomes including defective complexes that lack the 5’
exon. …………………………………………………………………………………….75
Genetic interactions of Spp382p ………………………………………………..86
Lowered Prp43p ATPase activity suppresses prp38-1 defect. …………...92
A point mutant of Aar2p also suppresses the prp38-1 defect. ……………....95
Physical interactions of Spp382p with a DnaJ-motif protein, Cwc23p. ……..98
Cwc23p is essential for normal cellular splicing. …………………………….110

vi

Genetic interactions of CWC23 ………………………………………………...115
Overexpression of multiple different splicing factors inhibits growth of the
spp382-1, prp38-1 double mutant suppressor strain. ……………………………124
Over expression of Sqs1p impairs cellular pre-mRNA splicing. …………..133
Sqs1p interactions with Spp382p and related factors. ……………………..140
CHAPTER 4: DISCUSSION ……………………………………………………...145
Future Directions- ………………………………………………………………165
APPENDIX 1. …………………………………………………………………………167
Spp381p – Prp38p –Snu23p form a stable heterotrimeric complex. ……..167
REFERENCES ……………………………………………………………………….172
VITA ……………………………………………………………………………………184

vii

LIST OF TABLES

Table 2.1 List of splicing factors used for over expression………………………..33
Table 3.1 Suppression by titration of an essential splicing activity……………….50
Table 3.2. Spp382-Cwc23 interaction……………………………………………….94
Table 3.3. Growth phenotypes of cwc23 mutants………………………………...103
Table A1.1. Two hybrid interactions………………………………………………..161

viii

LIST OF FIGURES
FIG. 1.1. Schematic representation of the DExD/H box helicases.

7

FIG. 1.2. Schematic representation of the Spliceosome assembly,
Catalysis and disassembly.

8

FIG. 1.3. Hypothetical model for the screen for the discard pathway.

17

FIG. 3.1 spp382-1 is a recessive, extragenic suppressor of the spliceosome
maturation mutant,

37

FIG 3.2. Alignments of the G-Patch and Spp382p protein

41

FIG. 3.3 Spp382p is essential for cell viability.

47

FIG 3.4. Spp382p is required for splicing.

52

FIG 3.5. Spp382p is required for normal intron metabolism.

55

FIG 3.6. Splicing efficiency of the spp382-1, prp38-1 strain

57

FIG 3.7. Spp382 mutants inhibit the first step of splicing.

60

FIG 3.8. Removal of Spp382p blocks splicing complex assembly at the
prespliceosome stage

63

FIG 3.9. Spp382p's relationship to the tri-snRNP.

66

FIG 3.10. Depletion of Spp382p inhibits stable tri-snRNP formation.

71

FIG 3.11. SnRNP profile of Spp382p depleted extracts.

74

FIG 3.12. Spp382p binds defective spliceosomes.

79

FIG 3.13. Exon release occurs before Spp382-TAP selection in lighter
spliceosomal complexes.

82

FIG 3.14. Genetic characterization of extragenic suppression.

86

FIG.3.15. spp382 alleles suppress weak substrate mutants.

87

ix

FIG 3.16. prp43 mutants also suppress prp38-1 defect.

89

FIG 3.17. aar2-D281N , a recessive point mutant, suppresses prp38-1.

91

FIG. 3.18 Physical interaction of Spp382p with the spliceosomal
DnaJ-like protein, Cwc23p.

95

FIG 3.19. Alignment of the Cwc23p homologs across species.

98

FIG 3.20. Growth characteristics of cwc23 mutants.

101

FIG. 3.21. Cwc23p is essential for efficient cellular splicing.

105

FIG 3.22 cwc23 mutants show inhibition of the first transesterification
reaction in splicing.

107

FIG. 3.23. Overexpression of Cwc23p exacerbates the growth of prp43
ATPase mutants.

110

FIG. 3.24. Genetic Interactions of Cwc23p.

113

FIG. 3.25. Two hybrid interactions of cwc23-1 and cwc23-2 with Spp382p.

115

FIG 3.26 Impact of overexpression under different conditions.

120

FIG. 3.27. G-patch alignment of Spp382p and Sqs1p.

128

FIG.3.28 . Overexpression of Sqs1p impairs splicing.

129

FIG 3.29. Two Hybrid interactions of Sqs1 with Spp382p and related factors. 133
FIG 3.30. Sqs1 null allele does not suppress prp38-1.

135

FIG 4.1. Model of spliceosome integrity (SPIN) surveillance and
intron release.

147

FIG. 4.2. Prp43p – Role in spliceosome and ribosome biogenesis.

153

FIG A1. Prp38p-Spp381p-Snu23p form stable heterotrimeric complex.

159

x

List of Files
Yeast Spliceosome.pdf

xi

CHAPTER 1
INTRODUCTION
Most eukaryotic genes have introns that must be properly removed by the
splicing apparatus to produce translatable mRNA. For many genes, the cellular
choice of when and where to splice a pre-mRNA is regulated by developmental
or environmental cues. For instance, current estimates (based on cDNA and EST
studies) indicate that more than half (50-65%) of all human genes are
alternatively spliced (Hastings and Krainer 2001). Regulated splicing is required
to promote much of normal developmental biology and genetic impairment of this
process accounts for over 100 human genetic disease states (Philips and Cooper
2000). In all cases studied to date, the regulation of alternative splicing has been
shown to occur at the level of spliceosome assembly (Valcarcel and Green
1996). The spliceosome is made up of 5 snRNAs and over 70 proteins (so
assembly is a complex event) (Brow 2002). By understanding how the normal
splicing apparatus assembles we hope to provide insight into the nature of the
enzyme’s active site, the possible steps of regulation, and, ultimately, to offer
suggestions for therapeutic application.

Splicing and the Spliceosome- An overview
Pre-mRNA splicing is the nuclear process by which introns are precisely
removed from cellular pol II transcripts in two transesterification steps within a
large RNA-protein complex called the spliceosome. In yeast, the spliceosome is
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composed of five small nuclear RNAs (snRNAs) and over 70 different proteins
(Brow 2002). Each snRNP in the spliceosome consists of one or two small
nuclear RNAs (snRNAs), a complement of common proteins and a subset of
snRNA specific proteins. In vitro, spliceosome formation precedes the chemical
steps (i.e., RNA cleavage/ ligation reactions) of splicing and involves an ordered
assembly of the snRNPs on the pre-mRNA (Konarska and Sharp 1986 ; Pikielny,
Rymond et al. 1986; Cheng and Abelson 1987). Though alternate models have
been proposed (e.g. the holospliceosome (Stevens, Ryan et al. 2002)), the
isolation of cellular U2, U5, U6 snRNP complexes (Ohi, Link et al. 2002; Wang,
Hobbs et al. 2003) and the studies of co-transcriptional pre-mRNA splicing
(Gornemann, Kotovic et al. 2005; Lacadie and Rosbash 2005) suggest that the in
vitro studies reflect what is happening in vivo.
The first clearly defined snRNP association involves recognition of the 5’
splice site and the branchpoint region by U1 in an ATP independent manner to
form the commitment complex (Legrain, Seraphin et al. 1988; Rosbash and
Seraphin 1991). The commitment complex is then matured by the addition of the
U2 snRNP at the expense of ATP resulting in the formation of pre-spliceosome.
Finally, the tri- snRNP (U4/U6.U5) is added as a single particle at the expense of
ATP to form the “snRNP complete” spliceosome. Once the spliceosome has
been formed it undergoes structural rearrangements to transform to a
catalytically active enzyme (Brow 2002). This results in loss (or displacement) of
U1 and U4 snRNAs from the complex that performs the chemistry of splicing.
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Chemistry of Splicing
Pre-mRNA splicing in both yeast and metazoans proceeds via two
transesterification reactions (Staley and Guthrie 1998; Stevens and Abelson
2002). In the first reaction, the 2’ hydroxyl group of an internal adenosine located
within the conserved branch point sequence (UACUAAC in yeast; the underlined
adenosine is the catalytic residue involved in the first transesterification reaction)
acts as an attacking nucleophile on the phosphate bond at 5’splice site-exon 1
junction. This results in the release of exon 1 and formation of the lariat
intermediate, a structure composed of exon 2 and the circularized intron. In the
next step, the 3’ –OH of the free exon 1 attacks the phosphate bond at the 3’
splice site – exon 2 junction. This results in ligation of the two exons and the
release of the lariat intron. The excised intron is then typically degraded, the
spliceosome disassembled and the mRNA exported to the cytoplasm for
translation.

Sequence requirements
Pre-mRNA splicing is a conserved process in eukaryotes, from the
budding yeast to humans. The consensus elements are related but not identical.
In yeast, the 5’splice site is G/GUAUGU where as in mammalian consensus
sequence is G/GURAGU (where R= purine residue and / is the site of cleavage).
The GU dinucleotide at the 5’ss is conserved in all eukaryotic pre-mRNA. The
branchpoint consensus sequence, UACUAAC is highly conserved in yeast while
in mammals it is more variable (YNYURAC, where Y= pyrimidine residue, R=
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purine residue and the underlined adenosine is the site of branch formation).
Some mutations in the branchpoint sequences in yeast abolish splicing
(Jacquier, Rodriguez et al. 1985; Jacquier and Rosbash 1986). In mammals,
such mutations typically result in use of alternate branchpoint near the 3’splice
site. A polypyrimidine tract is typically found downstream of the branchpoint and
upstream of the 3’ splice site in mammalian introns. In yeast, the spacing
between the branch point and 3’ is variable, ranging from 10 to 155 nucleotides
(Spingola, Grate et al. 1999). While not well conserved, some yeast introns
contain a short pyrimidine rich tract of 8-12 nucleotides (mostly uracil) which
ends one nucleotide upstream of the 3’ splice site. Unlike the case for many
mammalian introns, this sequence is not required for the first catalytic step in
yeast splicing (Rymond and Rosbash 1985). However, Guthrie and co-workers
showed that the presence of a uridine rich tract in yeast enhances the use of the
3’ splice site when present (Patterson and Guthrie 1991).
The 3’ splice site consensus is YAG/ (where Y= pyrimidine residue and / is
the site of cleavage) in both mammals and yeast. The 3’ splice site is
dispensable for the 5’cleavage and lariat formation in in-vitro (Rymond and
Rosbash 1985).
Metazoans also contain a second class of introns that are spliced by the
‘Minor’ or ‘ATAC’ spliceosome (reviewed in (Tarn and Steitz 1997; Patel,
McCarthy et al. 2002). The substrates differ in the consensus from the major or
the abundant class of pre-mRNA in that, the 5’ consensus sequence for them is –
AT/ (/ is the site of cleavage). UAUCCUUU, the branchpoint is longer and more
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tightly constrained -UCCUUAACU- and the 3’ splice site is YAC (or G) (Hall and
Padgett 1994). The snRNAs U4, U5 and U6 are common to both classes of
spliceosomes, however the U1 and U2 from the major class is replaced with U11
and U12 snRNAs.

DExD/H-box Proteins in Splicing
The spliceosome undergoes multiple rearrangements (in terms of the
snRNA- pre mRNA interactions, the snRNA –snRNA interactions and the
snRNA- protein interactions) during the assembly, catalysis and disassembly
events that define the spliceosome cycle. These rearrangements require ATP
hydrolysis and the presence of one of the eight DExD/H proteins (PRP5, SUB2,
PRP28, PRP5, BRR2, PRP16, PRP22 and PRP43) found in the spliceosome
(Figure 1.2).
The DExD/H proteins belong to the helicase superfamily II (SF2), the
largest helicase superfamily and are defined by the presence of seven motifs (as
shown in Figure 1.1). The motifs Q, 1a (Walker A motif), 1b (Walker B motif)
along with motif VI are required for ATP binding and hydrolysis. Mutations in the
motif III uncouple the ATP hydrolysis from the unwinding, i.e. these mutants are
capable of hydrolyzing ATP and yet fail to unwind the RNA (Tanner N.K., Cordin
O. et al. 2003; Linder 2006). For such mutations in the PRP2 and PRP43 genes,
the proteins are defective in splicing, indicating that both the ATP hydrolysis and
RNA unwinding activity is essential for the DExD/H box protein function
(Plumpton, McGarvey et al. 1994; Martin, Schneider et al. 2002).
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The DExD/H proteins are believed to remodel the spliceosome by
unwinding the RNA-RNA base pairings or by disrupting the RNA- protein
interactions or by doing both. Mutational analysis indicated that each protein of
this set plays a unique and non-redundant role in the spliceosome cycle in vitro
(Figure 1.2). However, while involvement in specific steps is clear, the
experiments conducted to date have yet to reveal the details directing substrate
specificity for this set of splicing factors.

Spliceosome Assembly and DExD/H proteins
The step that commits the pre-mRNA to splicing is the binding of the U1
snRNP to the pre-mRNA in an ATP independent process known as commitment
complex formation. Two separate commitment complex have been defined by invitro gel shift experiments. The first, CC1, requires only 5’ splice site to be
present on the pre-mRNA, while the second CC2 requires both 5’ splice site and
branch-point sequences for formation (Seraphin and Rosbash 1989), possibly
suggesting that CC1 is an intermediate in formation of the more complex and
slowly migrating CC2. The CC2 band contains Mud2p and branchpoint binding
protein (BBP) in addition to the U1 snRNPs. The binding of Mud2 and BBP to the
branch point occurs almost simultaneously and appears to be co-operative
(Berglund, Abovich et al. 1998). The U1 snRNA protein, Prp40p shows a two-
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FIG. 1.1. Schematic representation of the DExD/H box helicases. The 7
motifs of the DExD box helicases are shown below. The DExH box type of
helicases lack the Q motif. The motifs implicated in ATP binding are colored in
red, the blue areas indicate regions that interact with the RNA and shaded
regions in green are those that are important for intra-protein interactions.
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FIG. 1.2. Schematic representation of the Spliceosome assembly, catalysis
and disassembly. The colored circles represent the indicated snRNAs along
with their associated proteins (i.e. snRNPs) which associate with the pre-mRNA
in an ordered sequence to form the spliceosome. The spliceosome then
catalyzes the two transesterification reaction resulting in joining of the two exons
and release of the intron as the lariat. The conformational changes that the
spliceosome undergoes are believed to be bought about by the DExD/H proteins
(indicated at the steps they are implicated to act) at the expense of ATP.
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hybrid interaction with the branch-point protein, Bbp1p (Abovich and Rosbash
1997), thus implicating the U1 snRNP in recognition of the branchpoint. Mud2p
binds BBP and with U1 snRNP protein, Prp39p and thus bridging the two ends of
the intron and facilitating intron definition.
The U1 snRNA interaction with the conserved pre-mRNA sequences near
the 5’ splice site is stabilized by Yhc1p, the yeast homolog of the human U1C
snRNP protein (Zhang and Rosbash 1999). Prp28p, a DExD/H ATPase, is
implicated in the displacement of the U1 from the 5’splice site, a necessary event
for later steps in spliceosome assembly involving the U6 snRNP particle. The
requirement for Prp28p function can be bypassed through mutation of the YHC1
gene or by mutation of the U1 snRNA gene to weaken it’s association with
5’splice site. This result suggests that Yhc1p may be the target for Prp28p action
and that displacing Yhc1p destabilizes the U1 snRNA /pre-mRNA association
(Chen, Stands et al. 2001).
After formation of the commitment complex, the U2 snRNP binds to premRNA in an ATP dependant manner to form the prespliceosome. Curiously, the
U2 snRNA is 1000 nucleotides longer than its mammalian counterpart (Guthrie
and Patterson 1988). Complementation of a yeast snr2 (yeast U2) null allele with
the human U2 snRNA showed that yeast specific U2 snRNA sequence is
dispensable for growth (Igel and Ares 1988); (Shuster and Guthrie 1988). U2
snRNP binding to the pre-mRNA requires reorganization of the branchpoint
region that involves, at a minimum, displacement of the BBP and Mud2 proteins.
Yeast studies show that this is facilitated by two DExD/H- box proteins, Sub2p
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and Prp5p (Wells and Ares 1994; Fleckner, Zhang et al. 1997; Xu, Newnham et
al. 2004). The need for Sub2 protein is bypassed when MUD2, a non-essential
gene homologous to the mammalian U2AF65, is deleted (Kistler and Guthrie
2001). This suggests that SUB2 may promote removal of Mud2p in an ATP
dependant manner. Similarly, removal of the non essential gene, Cus2p renders
the U2 snRNP binding ATP independent but does not alleviate the need for the
protein Prp5p (Perriman and Ares 2000; Perriman, Barta et al. 2003). This
suggests that Prp5p ATPase activity is primarily needed for an internal U2
snRNP rearrangement step that involves Cus2p (Abu Dayyeh, Quan et al. 2002;
Perriman and Ares 2007). Prp5p has been suggested to tether U1 and U2
snRNPs in S. pombe (Xu, Newnham et al. 2004). Recently, our group has
provided evidence that Prp5p binds with the U2 snRNP protein Hsh155p,
providing a likely U2 snRNP target in the prespliceosome formation (Wang, He et
al. 2005).
The U4, U6 and U5 snRNAs are recruited to the spliceosome as the trisnRNP particle. The U4 and U6 snRNAs are the most phylogenetically
conserved snRNAs in primary sequence and size (Siliciano, Brow et al. 1987);
(Brow and Guthrie 1988) and are tightly associated within this particle via
extensive RNA-RNA base pairing. U4 snRNA is not essential for catalysis but
acts as a chaperone for U6 snRNA. U6 snRNA plays an important role in splicing
as mutations in U6 can block either the first or the second chemical step of the
reaction (Fabrizio and Abelson 1990; Madhani, Bordonne et al. 1990). U6 snRNA
interacts with the 5’ pre-mRNA splice site via its conserved ACAGAG sequence
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(Sawa and Abelson 1992); (Lesser and Guthrie 1993; Kim and Abelson 1996).
Mutations in any of these nucleotides result in temperature sensitivity or lethality
(Madhani, Bordonne et al. 1990). The U6- 5’ splice site interaction is prerequisite
for U4-U6 unwinding (Li and Brow 1996). The first cleavage and ligation reaction
occurs only after the dissociation (complete or partial) of U4 snRNA.
The U5 snRNA, in particular the conserved loop I sequence, has been
crosslinked in both yeast and mammals to exon sequences near the 5’ and the 3’
splice site borders (Sontheimer and Steitz 1993; Newman, Teigelkamp et al.
1995). This result allows one to speculate that the role of U5 snRNA is to tether
the exons in order to facilitate the second transesterification reaction. Indeed
Prp8p, a core U5 snRNP protein, interacts extensively with both the 5’ and the 3’
splice site region prior to the second step (Teigelkamp, Newman et al. 1995;
Umen and Guthrie 1996). Moreover, Prp8p mutants can suppress either 5’ or 3’
splice site mutations (Query and Konarska 2004). It is proposed that Prp8p
functions at the catalytic core of the spliceosome by stabilizing the snRNA/premRNA interactions needed for the second step of splicing (Collins and Guthrie
1999); (Grainger and Beggs 2005).
Throughout spliceosome assembly, structural rearrangements are
required to configure a catalytically active enzyme. In addition to the Sub2p and
Prp5p-dependent steps, these include U1 snRNA displacement from 5’ splice
site, dissociation of U4 snRNA from the splicing complex, formation of new base
pairing between U6 and U2, and interaction of the U6 and U5 snRNAs with the
pre-mRNA substrate. Brr2p is a U5 snRNP specific RNA helicase thought to
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unwind U4.U6 intermolecular helices (Lin and Rossi 1996); (Kim and Rossi
1999). Brr2 has RNA dependant ATPase activity in vivo (Raghunathan and
Guthrie 1998). Brr2 interacts with many other splicing factors in yeast two hybrid
assay (van Nues and Beggs 2001). This suggest that Brr2 may play a role in
addition to the U4/U6 snRNA unwinding. Indeed, recent evidence from the Staley
lab suggests that Brr2p may play a role in both activation and disassembly of the
spliceosome via the activity of the GTPase, Snu114p (Small, Leggett et al. 2006).
Several other proteins also function with the DExD/H-box proteins in
spliceosome activation. For instance a mutant derivative of Prp38p (prp38-1p), a
small tri-snRNP protein (28 kDa) with an acidic, serine rich C-terminus, locks the
fully assembled spliceosome in an inactive state at the restrictive temperature
(Blanton, Srinivasan et al. 1992);(Xie, Beickman et al. 1998) Since U4/U6 are still
bound together in this mutant, Prp38p acts as a maturation factor, i.e., the
spliceosome assemble without Prp38p but arrest in the pre-catalytic stage prior
to U4/U6 dissociation. Related observations have been made for certain prp8p
mutants (Kuhn, Reichl et al. 2002). Mutants of another U5 protein, Snu114p, a
GTPase, with homology to the ribosome elongation factor EF-2, show
accumulation of the splicing complex with the U4/U6 still bound together,
suggesting that this GTPase protein plays a role in the unwinding (Fabrizio,
Laggerbauer et al. 1997). The effector proteins, Prp38p, Prp8p or Snu114p are
not helicases (based on absence of canonical helicase motifs), but may recruit or
activate one such DExD/H proteins in splicing.
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DExD/H box protein involvement in post-assembly events.
As discussed above, pre-mRNA splicing proceeds via two
transesterification steps. Spliceosomes assemble in the absence of Prp2p, but
Prp2p is required for conformational changes that promote the first cleavage –
ligation reaction to generate the free upstream exon and the branched lariat
intermediate (Yean and Lin 1991). While not a stable spliceosomal protein, the
transient association of Prp2p accompanied by ATP hydrolysis is believed to be
necessary for the formation of the catalytic core of this enzyme. Prp2p has been
observed to interact directly with the pre-mRNA (Teigelkamp, McGarvey et al.
1994) but it remains uncertain how this protein is recruited to the spliceosome or
how the ATPase activity might be regulated once bound. Intriguingly, Woolford
and co-workers (Roy, Kim et al. 1995) identified Spp2, a yeast G-patch
containing protein, in a genetic screen for dosage suppressors of the
temperature sensitive prp2 mutants. Subsequent work by Lin and co-workers
(Silverman, Maeda et al. 2004) showed that the Prp2p – Spp2p interaction was
necessary for the Prp2p association with the spliceosome, leading to the
hypothesis that Spp2p may direct (or activate) the Prp2p DExD/H protein in the
spliceosome.
Prp16p associates with the spliceosome after the first catalytic event and
promotes this 3’splice site cleavage and formation of the mature message in an
ATP dependant manner (Schwer and Guthrie 1992). The Guthrie lab has shown
that Prp16p ATPase activity results in a conformational change that leads to
protection of the 3’ splice site from RNase H cleavage, and is suggested to
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enhance the binding of at least 2 proteins (Prp8p and Slu7p) to the 3’ splice site
(Umen and Guthrie 1995).

Disassembly and DExD/H box proteins
After activation, the spliceosome performs the two transesterification steps
and the intron is removed. Once the two exons are joined together, the Prp22
DExH protein promotes mRNA release (Wagner, Jankowsky et al. 1998). Prp22p
has been shown to have an earlier role in splicing for transcripts where the
distance between the branchpoint and the 3’SS is more than 21 nucleotides. For
such splicing substrates, Prp22p depleted extracts in vitro arrest splicing after the
first chemical step, resulting in the accumulation of lariat intermediates and free
exon. However, unlike mRNA release, this function in promoting the second
transesterification does not require ATP hydrolysis by Prp22p (Schwer and Gross
1998).
After mRNA release, the lariat intron is released from the spliceosome
(through the ATPase activity of Prp43p (Arenas and Abelson 1997); (Martin,
Schneider et al. 2002). The released lariat intermediate is then linearized by the
2’-5’phosphodiesterase, Dbr1p (Chapman and Boeke 1991) and subsequently
degraded. The disassembled snRNPs are then recycled for a new round of
splicing.
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Fidelity and DExD/H box helicase
The removal of introns with single nucleotide precision is generally
imperative to produce functional mRNA. Yet, how fidelity is achieved by the
spliceosome is a major unanswered question in the field. Burgess and Guthrie
found that a single mutation in the helicase domain of the Prp16p DExD/H box
protein that diminishes its ATPase activity decreased splicing fidelity by allowing
use of an aberrant branchpoint nucleotide UACUAACÆ UACUACC. They
proposed a “kinetic proofreading” model where splicing fidelity was coupled to
ATP hydrolysis (Couto, Tamm et al. 1987; Burgess, Couto et al. 1990; Burgess
and Guthrie 1993). Similar to Prp16p, Prp22p mutants with lowered ATPase
activity also allow for the use of pre-mRNA substrates aberrant 3’ss substrates
(Mayas, Maita et al. 2006). Key to this “kinetic proofreading” mechanism is the
predicted existence of a “discard pathway” that removes defective complexes
should these persist after the step of ATP hydrolysis. It has been proposed that
at each ATP driven step, the spliceosome could discard unsuitable substrates via
the discard pathway (Query and Konarska 2006). Two benefits are envisioned by
this activity, improved mRNA fidelity through suppression of aberrant splicing and
the turnover of nonfunctional complexes, the latter being essential since splicing
complexes are present in limiting amounts. Thus, while the components are
unknown, such a discard pathway has been speculated to act throughout the
spliceosome cycle as a quality control system for complex integrity (Konarska
and Query 2005).
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With this in mind, we postulated a simple hypothesis, blocked or stalled
partially active spliceosomes could be suppressed either by directly enhancing
their splicing efficiency or by decreasing the ability of the discard pathway to
recycle them. To address this, I initiated this dissertation project with a genetic
screen to identify possible effectors of the discard pathway. Rather than using a
substrate-specific selection approach similar to that which identified PRP16, we
chose to use a mutation within a core spliceosomal protein that is required for
pre-mRNA splicing. This approach was reasoned to be much more stringent and
less likely to identify substrate-specific suppressors. We opted to use prp38-1, a
mutation in an essential component of the U4/U6.U5 tri-snRNP particle identified
by our laboratory (Blanton, Srinivasan et al. 1992)). This mutation results in the
assembly of kinetically impaired spliceosomes that appear to assemble normally
but splice at a much reduced rate that is exacerbated by elevated temperature
(Xie, Beickman et al. 1998) resulting in a tight, temperature sensitive growth (and
splicing) defect. I reasoned that suppressors of prp38-1 might occur through
increased mRNA synthesis brought about by either direct improvement in
splicing efficiency or by reduced activity of the proposed discard pathway –
thereby providing “more time” for the defective spliceosomes to process mRNA
before dissociation. This model is illustrated in figure 1.3.
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FIG. 1.3. Hypothetical model for the screen for the discard pathway. In a
simple model of splicing, the pre-mRNA is either spliced or discarded. One can
speculate that under normal conditions, the rate of splicing is far greater than the
rate of spliceosome disassembly and pre-mRNA degradation (Panel A as would
be the case in a normal wild type cell). However when the spliceosome is
blocked or stalled, as shown for prp38-1 (panel B), it is likely to be disassembled
and the pre-mRNA degraded. By extension, increased spliceosome stability is
expected to increase the likelihood of processing by a partially active complex.

Copyright © Shatakshi Shreekant Pandit 2007
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CHAPTER 2
MATERIALS AND METHODS
Yeast genetics and plasmid construction.
Yeast Strains
Strain

Genotype

MGD353-46D

α, ura3-52, trp1-289, leu2-112,113, his

Ts192

α, ura3-52, trp1-289, leu2-112,113, his, prp381

prp38-1

Mat A, prp38-1, ura3-52, trp1-289, leu2-112,
113, his3, arg4

SPM301

α, ura3-52, trp1-289, leu2-112,113, his, prp381,spp382-1

MGD353-13D

Mat A, trp1-289, ura3-53, leu2-3,112, arg4,
ade2

Prp38::KAN,

MatA, ura, leu2, his, prp38::KAN, YCp50-

YCp50-PRP38

PRP38 -URA3

Spp382-1

α, his3∆1,leu2∆0,ura3∆0,spp382::KAN,
YcpLac111-spp382-2 -LEU2)

Spp382-2

α, his3∆1,leu2∆0,ura3∆0,spp382::KAN,
YcpLac111-spp382-2-LEU2

Spp382-3

α, his3∆1,leu2∆0,ura3∆0,spp382::KAN,
YcpLac111-spp382-3 -LEU2

Spp382-4

A/α, his3∆1, leu2∆0, ura3∆0, spp382::KAN,
p416- ∆spp382- URA3
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Spp382-5

α, his3∆1,leu2∆0,ura3∆0 , spp382::KAN,
YcpLac111-spp382-5 - LEU2

Spp382-6

A/α, his3∆1,leu2∆0,ura3∆0 , spp382::KAN,
YcpLac111-spp382-6 - LEU2
A, his3∆1,leu2∆0,ura3∆0,CLF1-TAP-HIS,
spp382::KAN, YcpLac111-spp382-6- LEU2

Spp382-7

α, his3∆1, leu2∆0, ura3∆0, trp1-289,
spp382::KAN, YcpLac111-Spp382-7 - LEU2

Spp382-8

Α, his3∆1,leu2∆0,ura3∆0, trp1-289,
spp382::KAN, YcpLac111-Spp382-8 - LEU2

Spp382-9

α, his3∆1,leu2∆0,ura3∆0,spp382::KAN,
YcpLac111-Spp382-9 - LEU2

GAL1::SPP382 α, his3∆1, leu2∆0, ura3∆0, spp382::KAN,
pbm150-SPP382 – URA3
Spp382-TAP

A, , his3∆1, leu2∆0, ura3∆0, met15∆0 Spp382TAP

JM640

A, prp8-1(G2347D),his7, ura1, lys2, ade1,
ade2, tyr1

JM847

A, prp8-2 (P1015S),his7, ura1, lys2, ade1

prp43-R242A

α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2101, ade2-101, lys2-801, prp43::KAN, p358prp43-R242A – TRP1

prp43-H218A

α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2101, ade2-101, lys2-801, prp43::KAN, p358prp43-H218A-TRP1
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prp43-S247A

α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2101, ade2-101, lys2-801, prp43::KAN, p358prp43-S247A –TRP1

prp43-T249A

α ura3-52, trp1-63, his3 ∆200, leu2-1, ade2101, ade2-101, lys2-801, prp43::KAN, p358prp43-T249A- TRP1

PJ69-4a

a trp1-901 leu2-3,112, ura3-52, his3-200, gal4
, gal80 , LYS2 : : GAL1–HIS3, GAL2–ADE2,
met2 : : GAL7–lacZ

SPC1

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, pGAL1::CWC23 - URA3

Cwc23-1

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-1- TRP1

Cwc23-2

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-2 - TRP1

Cwc23-3

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-3 - TRP1

Cwc23-4

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-4 - TRP1

Cwc23-5

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-5 - TRP1

Cwc23-6

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-6 - TRP1

Cwc23-7

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, YCpLa22-cwc23-7 - TRP1

Cwc23-8

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, pGAL1::CWC23, YCpLa22cwc23-8 - TRP1
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Cwc23-9

A/α, his3∆1,leu2∆0,ura3∆0, trp1-289,
cwc23::KAN, pGAL1::CWC23, YCpLa22cwc23-9 - TRP1

Cwc23-TAP

A, , his3∆1, leu2∆0, ura3∆0,met15∆0 Cwc23TAP

Sqs1::KAN

Α , his3∆1, leu2∆0, ura3∆0, lys2∆0,
sqs1::KAN

Microbial Methods
E.coli Methods
E. coli was cultured in 2 x YT medium (1.6% bacto tryptone, 1% bacto
yeast extract, 0.5% NaCl, pH 7.5) at 37 C with ampicillin (@ 100µg/ mL) added
when necessary. The strain used for sub cloning and plasmid DNA purification
was TG1. The cells were made competent by the calcium chloride treatment and
alkaline lysis was used for small-scale (miniprep) isolation of DNA (Sambrook K.
J., Fritsch E. f. et al. 1989).
Yeast Methods
Yeast cells were routinely cultured at 25 °C in either rich media (1% bacto
yeast extract, 2% bacto peptone, 2% sugar (glucose or galactose) or in selective
drop out media as indicated. Yeast transformation was done by the lithium
acetate method of Ito et al. (Ito, H., Fukuda, Y. et. Al. 1983) with the isolation of
transformants on selective media (Sherman F., Finks G. R. et al. 1986).
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For generating double mutants, the indicated strains were crossed and the
diploid selected on a drop out medium that selects against the individual haploid
parents. Then meiosis was induced by growth on nitrogen-limited sporulation
medium. The tetrads were dissected using an Olympus BH2 microscope fitted
with a micromanipulator as described by Sherman et al (Sherman F., Finks G. R.
et al. 1986). The meiotic offspring from at least 20 tetrads were scored for
genotypic markers on drop out media and for mating type by crossing to tester
strains (see Strain List) and selecting for the resultant diploid on selective drop
out media. The presence of specific chromosomal KANR knockouts was checked
by growth in YPD with G418 (concentration of 200 mg/liter) and by direct PCR
analysis of the mutant allele. For other mutants, the defective allele was
confirmed by sequencing the PCR product, scoring for a restriction site
polymorphism, and by complementation with the corresponding wild type allele.
Mutants were checked for altered growth by streaking cultures at 19, 23, 30, 35
and 37 °C along with controll mutant and wildtype strains.
Yeast two-hybrid analyses were conducted by insertion of full-length open
reading frame (ORF) PCR fragments (See Primer List) into the GAL4 activation
domain plasmid pACT and the GAL4 DNA binding plasmid pAS2 (Clontech
Laboratories Inc., Palo Alto, CA). For all the clones, except PRP43, PCR
products were digested with BamH1 and ligated to the pAS2 (BamH1 digested)
or pACT (BglII digested) vectors. For the pAS2-PRP43 construct, the YCpLac33PRP43 subclone was digested with Xba1/Pst1 and the PRP43 containing
fragment and isolated from an agarose gel using a Qiagen DNA Purification Kit.
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This DNA was then ligated to a pAS2 Xba1/Pst1 digested vector. For all
constructs, reporter gene transactivation was scored in yeast strain PJ69-4A.
Unless otherwise noted, two hybrid growth results were compared after 3 days
growth at 30°C on medium lacking adenine and on histidine-deficient medium
supplemented with 5 or 20 mM 3-aminotriazole as described previously (James,
Halladay et al. 1996).
For the checking the cis suppression, the spp382-1and spp382-6
transformed with the reporter plasmids were patched and grown on a minimal
plate lacking uracil at room temperature for two days. After two days, a 5 ml
solution of X-Gal agar solution was overlayed onto the plate as reported in CSH
Manual with the Magnesium and Phosphate concentrations adjusted to 5X the
standard plate concentration to allow for the normal diffusion of the 5 ml overlay
buffer/salts mix to the rest of the plate. The plates were incubated at room
temperature for 16 hours and scanned.

Yeast Suppressor Screen
Spontaneous suppressors of the prp38-1 mutant strain, ts192 (Blanton,
Srinivasan et al. 1992) were selected by growth at 37 °C on rich medium (YPD
(Chen, Frand et al. 1998)). Colonies were backcrossed to the wildtype strain,
MGD353-13D, sporulated, and the resultant offspring scored for the
reappearance of temperature sensitivity expected when the mutation is due to an
extragenic suppressor. To test for dominance, the isolated suppressors were
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mated to the prp38-1 haploid yeast strain SP101 and the diploid assayed for
growth at 37 °C.
The wildtype SPP382 allele was isolated by transforming SPM301 with a
centromeric yeast DNA library (Rose, Novick et al. 1987) and screening replica
plates of the transformants for the re-acquisition of temperature sensitivity. A
PCR and sub-cloning approach (vector YCplac33 (Gietz and Sugino 1988)) was
used to identify SPP382 as the relevant gene. (See Primer List for primer
sequences for Ylr424w-1 and Ylr4242w-4).
Linkage analysis was used to confirm that the recovered gene, SPP382,
was the wildtype allele of the original mutation and not an unlinked low dose
suppressor. A PCR product containing the SPP382 orf and 500 base pairs of
upstream sequence was cloned into the BamH1 site of YIpLac211, an integration
vector. The resultant plasmid was cut at a unique site (Hpa1) within the insert to
direct integration to homologous chromosomal locus. The parent suppressor
strain, SPM301, was transformed with the linearized DNA resulting in a Ura+,
temperature sensitive strain. The site of integration was checked by Southern
blot analysis using radiolabeled SPP382 gene fragment as a probe. This
transformed strain was mated to a wild type (MGD353-13D) and the resulting
diploid sporulated. Meiotic progeny from 21 tetrads were scored for temperature
sensitivity and segregation of the URA3 marker.
The wildtype allele of a second suppressor, AAR2, was identified by
complementation of SPE401 using 133 genes related to RNA processing (Listed
in Table 1) selected from an ordered set of yeast genes expressed with a GAL1
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promoter. Each transformant was then screened for temperature sensitivity.
Added support that the recovered gene encodes the suppressor allele was made
by DNA sequence analysis of the mutant allele.

Mutagenesis
Site directed mutagenesis was done by inverse PCR with mutagenic
oligonucleotides (sequences in the Primer List) and the Expand Long polymerase
(Roche Biochem). The target genes were (a) the SPP382 orf plus 450 bp of 5’
flanking sequence (amplified using primers Ylr424w-1 and Ylr24w-2, see Primer
list for Spp382) subcloned into the BamH1 site of the plasmid,YCPlac111 (Gietz
and Sugino 1988) and (b) the CWC23 orf plus 100 bp of 5’ and 100 bp of 3’
flanking sequence (amplified using primers cwc23-1 and cwc23-2, see Primer list
for the rest) cloned into BamH1 site of YCpLac22 (58). Random mutagenesis of
the CWC23 orf was done with the Mutazyme enzyme (Stratagene) and ORF
specific primers (See Primer List). The mutated CWC23 orf was used as a mega
primer to amplify a full length YCpLac22-CWC23 plasmid following the
manufacturer’s protocol (Stratagene). In all cases, plasmids containing the
mutated gene were transformed into yeast where the corresponding
chromosomal allele was replaced with the Kanamycin resistance gene and a
second plasmid was present bearing a wild type allele linked to URA3 selectable
marker. After isolation of the double transformant, the wild type copy was
shuttled out by growing the strain on 5 flurooratic acid (Bender and Pringle 1991).
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The mutagenized gene was then scored for lethality (failure to grow on the FOA
plates) and for temperature or cold sensitivity at 19, 25, 30, 35 and 37 C.
For generating the GAL1::spp382-4 promoter fusion strain, SPP382 was
amplified with primers Ylr424w-1 and Ylr424w-4 (see Primer List below), the
PCR product was digested with Cla1, gel purified and blunt ended with T4 DNA
Polymerase (New England Biolabs), phosphorylated, and then ligated into the
Sma1 site of the GAL1 yeast expression vector, p416 (Mumberg, Muller et al.
1994). The plasmid was transformed into a spp382::KAN / SPP382 heterozygous
diploid yeast strain the desired haploid strain obtained after sporulation as
described above.

RNA Methods.
Northern Analysis: Total cellular RNA was recovered from yeast grown
under permissive or non-permissive conditions (for temperature or sugar source)
and assayed by northern blot from a 1% agarose/formaldehyde gel as described
by Sherman et. al (Methods in Yeast Genetics). The snRNAs were resolved on a
5% polyacrylamide, 7M urea denaturing gel and electroblotted to a Nytran
membrane prior to hybridization. Uniformly radiolabeled 32P probes were made
with the indicated templates using the Random Primer labeling kit (Invitrogen)
following the manufacturer’s protocol. The RNA bands were visualized with
Typhoon 8600 phosphorimager (GE Biosystems) and, where, indicated
quantified with ImageQuant software.
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Primer Extension Analysis: The yeast strains transformed with the
intron-bearing GAL1-RPS17 fusion gene on plasmid HZ18 (Teem and Rosbash
1983) were cultured in media lacking uracil with galactose as the carbon source.
Total RNA was isolated as described above. A 5’ end labeled oligonucleotide
complementary to exon 2 (RB1 (see primer list), (Teem and Rosbash 1983) was
used for primer extension with reverse transcriptase (Promega) as described by
Rymond et al (Rymond, Pikielny et al. 1990). The cDNA products were resolved
on a 5% polyacrylamide, 7M urea denaturing gel and visualized with the Typhoon
8600 phosophoimager.
In Vitro Splicing Assay and Spliceosome Assembly: Splicing reactions
and spliceosome assembly were performed essentially as previously described
(Pikielny, Rymond et al. 1986). Splicing reactions were assembled on uniformly
radiolabeled pre-mRNA prepared from EcoRI cleaved SPRP51A DNA (renamed
RPS17A) by in vitro transcription using SP6 RNA polymerase. The reactions
were resolved on 5% polyacrylamide, 7M urea denaturing gel gels and the bands
were visualized using the Typhoon 8600 phosphorimager.
Co-immunoprecipitation of snRNAs: 20 µl of the SPP382-Tap whole
cell extract (see below) was mixed in a siliconized microfuge tube with 150 µl of
buffer A [150 mM KCl, 2 mM Mg(OAc)2, 50 mM HEPES, pH 7.5] and 20 µl of
rabbit IgG agarose beads (Sigma) for 2 hours at 4oC. The beads were recovered
by brief low-speed centrifugation (2,000 RPM, 1 minute), and washed 6 times
with 800 µl of the Buffer A. The snRNAs were then released by the addition of an
equal volume of 2× PK buffer (200 mM Tris-HCl pH 7.5, 25 mM EDTA, 300 mM
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NaCl, 2% SDS, 2 mg/ml proteinase K) and incubating for 10 min at 37°C. The
samples were then phenol extracted, the snRNAs ethanol precipitated and
resolved on a 5% polyacrylamide, 7M urea denaturing gel which was blotted and
hybridized as indicated above.
SnRNP analysis: The native snRNP complexes present in yeast splicing
extracts were resolved on 4% polyacrylamide (80:1 acrylamide::bisacrylamide)0.5% agarose gels run in 50 mM Tris-glycine buffer (pH 8.8) overnight at a 30-V
constant voltage and then electroblotted to a Nytran membrane. The snRNPs
were visualized by hybridizing the membrane with snRNA specific radiolabeled
probes.
Protein Purification and Mass Analysis.
Splicing extracts were prepared under liquid nitrogen with a Spex
Certiprep 6850 freezer mill as published (Wang, He et al. 2005). TAP- tagged
Spp382 was purified from 20 liters of cells by IgG agarose and calmodulin
agarose affinity selection using standard procedures (Puig, Caspary et al. 2001)
with NaCl increased to 450 mM in the binding and wash steps. The proteins
released from calmodulin agarose were then resolved by two dimensional liquid
chromatography followed by mass analysis with a Deca mass spectrometer
(ThermoFinnigan) as described (Wang, Hobbs et al. 2003). The mass-intensity
lists were screened against the non-redundant NCBI protein database with
MASCOT software at the default cutoff score of 20.
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In vivo labeling and TAP purifications
Yeast proteins were 35S labeled by the addition of 1 mCi of Trans-35S (ICN)
to 1 ml of yeast concentrated from 10 ml of culture (at an optical density at 600
nm of 1.0) grown in low sulfur medium. The cells were incubated with the labeled
amino acids at 30°C for 3 hr and harvested as described in Wang et al (Wang,
Hobbs et al. 2003). TAP purification was then performed scaled down for use
with the reduced volumes as recently described (Wang and Rymond 2003).
Where indicated, the NaCl concentration was adjusted to 150, 300, or 500 mM
during the binding and wash steps of protein A agarose chromatography.
Proteins were precipitated with 6% trichloroacetic acid and the samples resolved
on a sodium dodecyl sulfate-5 to 10% gradient polyacrylamide gel with
Benchmark molecular weight markers (Invitrogen). The labeled bands were
visualized with a Typhoon 8600 phosphorimager.
Western blotting
Western transfers of the TAP extracts on nitrocellulose membrane were
blocked for half an hour in 5% milk (in PBS) and then incubated for 2 hours with a
1:1,000 dilution of rabbit anti-peroxidase primary antibody (Sigma) followed by
incubation for 1 hour with a 1:1,000 dilution of goat anti-rabbit immunoglobulin G
(IgG) (heavy-plus-light chain)-alkaline phosphatase secondary antibody
(Gibco/BRL). The membranes were then developed with 5-bromo-4-chloro-3indolylphosphate-nitroblue tetrazolium according to the supplier's
recommendation.
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Spp382p depletion
To deplete Spp382p in vivo, GAL1::spp382-4 yeast strain was grown at
25°C in YP broth with 2% galactose to an optical density at 600 nm of
approximately 0.20. The yeast were then harvested by centrifugation and
resuspended in 2x the original culture volume with YP broth containing 2%
glucose. The culture was incubated at 37°C for 16 h prior to extraction of RNA or
the preparation of yeast whole cell extract as described above.
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Primer List For Spp382:
Ylr424w-1

CGG GAT CCC AAT GCC TTCCTT TAA ~450 bp upstream
AAT

Ylr424w -2

GCG GAT CCT GAG GTC AAG GGC -stop codon, end of
CCA TAA ATA

Ylr424w -3

gene.

GGA TCC ATG GAG GAT TCG GAC @

site,

for

GAL1 construct

TCC AAC
Ylr424w -4

start

GGA TCC TAG AGG TCA AGG GCC @ end of gene
CAT AA

Spp382dn

TTG GAA ACA TTT CAA GGG CAA

50 bp downstream

Ylr424w -5

TAG TAC AAC CGA GAG AGG TCG

50 bp upstream

Ylr424w -6

CCC GAT AAA ACT TAG CAC TTG

Middle Æ start

Ylr424w -7

ATC GAC AGC GCT ATC ACC CTA

middleÆ end

Ylr424w -8

CCG GAT CCT CAT GGA GGA TTC Forward

for

two

GGA CTC CAA

hybrid

Ylr424w -9

GTT TTA GGC GAA GCG TTG TTA

Middle to end

Ylr424w -10

GTC ATA TCA AAC CCT TCC CAA AA

Middle to start

Ylr424w -11

AAG ATT GGT GCT ATT TTA AAA

middleÆ end

Ylr424w 12

GCT CGA GTA TCT ATC CGA TTG

Middle Æ start

Ylr424w -13

AAA GAC TTA ACC TCC AAT GAA

For allele detection

Ylr424w -14

GAA GAC TTA ACC TCC AAT GAA

For allele detection
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Primer List For The Rest:
Cwc23-1

CCC GGA TCC TC ATG CCA GGA

Forward for two hybrid

CAC GAA TTG
Cwc23-2

CTA GGA TC CTA GTC GAG TAG

Reverse for two hybrid

GAT AGG TTC
Cwc23-up

CCC AAG CTT GCA TAT TAT CTC

100 bp upstream

GCA
Cwc23-dn

GGC GGA TCC TTT CCT TTT CTT

100 bp down stream

TTT CTT
Prp43-1

ATC AAG ATC TCA ATG GGT TCC

Forward for two hybrid

AAA AGA AGA TTC
Prp43-2

CTA TAG ATC TCT ATT TCT TGG

Reverse for two hybrid

AGT GCT TAC TC
Ynl224c-1

CCC GGA TCC TAA TGG CAA AAA

Forward for two hybrid

GGC ATA
Ynl224c-2

CCC GGA TCC GTG TAT ATT ACC

Reverse for two hybrid

ATA GAT
Aar2-1

CCC GAA TTC GAA TGG TAA ACA

400 bp upstream

TTT GGT
Aar2-2

CCC AAG CTT GAT ACA TCC CTT

200 bp down stream

AAC CAT
Aar2-3

CCC GGA TCC TAA TGA ATA CTG

Forward for two hybrid

TAC CAT TT
Aar2-4

CCC GGA TCC TTA TGG CCT TTG

Reverse for two hybrid

GTA ATA
RB1

CGC TTG ACG GTC TTG GTT C
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For primer extensions

Site Directed Mutagenesis Primer List:
Spp382-3: ANN GTT GCG GGA AAA GGC CTT
Spp382-4: TCC CAT ACT CGA AAG TAA CTT
Spp382-A2: GCT GCA GCT ATT GAA GCA AAA TTT
Spp382-A2R: AAT TGT GTC TTT GAT CTT ATC GTC
Spp382-A3: GCT GCA GCT TTC GAT TTG AGA CAG
Spp382-A3R: TAA TGT AGA TTT ATC AAG GTG GTA
Spp382-L232: GCC CTT TCT GAA TTG GAG GTT
ACT
Spp382-L232R: CCT CTC TTG TCC ATA ATA TTC
TTT
Cwc23-H1: CAA CCT GAC AAA CAC CCG GAC
Cwc23-H2: CAG CCG GAC AAT CCA TCA ATT
Cwc23-H2r: TTT GTC AGG ATG ATA CTT CAG
Cwc23-H3: CAA CCT GAT TTA TTG CAA ATC
Cwc23-H3R: TGG TGT GGT GGT GGG TAT CGT
Cwc23-F65: TTA CAC TTA TTA TCG ACC GCA
Cwc23-F65R: TTT GTG TAT AAT TGA TGG ATT
Cwc23-A1: GCG GCC GCT AAA TAC AGG ACC CTT
Cwc23-A1R: TTG GGG CAA ATC ATC GTA GAT GGT
Cwc23-A2: GCG GCC GCT AAA CAC CCG GAC AAT
Cwc23-A2R: ATA CTT CAG GGC AAG GGT CCT GTA
Cwc23-A3: GCG GCC GCT AAT AAT AAA TCA AAC
Cwc23-A3R: GAA GTT GTC AAG GAC AAT TCT CAA
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List of splicing factors used for over expression.
No
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

Gene
AAR2
BRR1
CBC2
CDC40
CEF1
CLF1
CUS1
CUS2
CWC2
CWC15
CWC22
CWC25
DIB1
ECM2
EXO84
HSH49
GSP1
IST3
ISY1
LEA1
LSM2
LSM3
LSM4
LSM5
NAB2
LSM7
LSM8
NTF2
LUC7
MER1
MSL1
MSL5
MUD1
MUD2
NAM8
NTC20
PRP2
PRP3
PRP4
PRP5
41 PRP6

42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81

ORF
YBL074C
YPR057W
YPL178W
YDR364C
YMR213W
YLR117C
YMR240C
YNL286W
YDL209C
YDR163W
YGR278W
YNL245C
YPR082C
YBR065C
YBR102C
YOR319W
YLR293C
YIR005W
YJR050W
YPL213W
YBL026W
YLR438C-A
YER112W
YER146W
YGL122C
YNL147W
YJR022W
YER009W
YDL087C
YNL210W
YIR009W
YLR116W
YBR119W
YKL074C
YHR086W
YBR188C
YNR011C
YDR473C
YPR178W
YBR237W
YBR055C
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PRP8
PRP9
PRP11
PRP16
PRP19
PRP21
PRP22
PRP24
PRP28
PRP31
PRP38
PRP39
PRP40
PRP42
PRP43
PRP46
RDS3
RPL30
SAD1
SKY1
SLU7
SMB1
SMD1
SMD2
SMD3
SME1
SMX2
SMX3
SNP1
SNT309
SNU13
SNU56
SNU66
SNU71
SNU114
SPP2
SPP381
SPP382
SUB2
SYF1

YHR165C
YDL030W
YDL043C
YKR086W
YLL036C
YJL203W
YER013W
YMR268C
YDR243C
YGR091W
YGR075C
YML046W
YKL012W
YDR235W
YGL120C
YPL151C
YPR094W
YGL030W
YFR005C
YMR216C
YDR088C
YER029C
YGR074W
YLR275W
YLR147C
YOR159C
YFL017W-A
YPR182W
YIL061C
YPR101W
YEL026W
YDR240C
YOR308C
YGR013W
YKL173W
YOR148C
YBR152W
YLR424W
YDL084W
YDR416W

82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121

SYF2
USA1
YHC1
YJU2
NTR2

YGR129W
YML029W
YLR298C
YKL095W
YKR022C
YLR132C
LSM1
YJL124C
CWC23 YGL128C
BUD13 YGL174W
BuD31
YCR063W
PML1
YLR016C
GCN2
YDR283C
CDC33 YOL139C
DHH1
YDL160C
HTA1
YDR225W
IMG1
YCR046C
MRP7
YNL005C
MRP13 YGR084C
RVB2
YPL235W
KRS1
YDR037W
TOS4
YLR183C
ERB1
YMR049C
LIN1
YHR156C
UTP21
YLR0409C
YMC6
YML025C
NPL3
YDR432W
SRB2
YHR041C
YEF3
YLR249W
TIF4631 YGR162W
TIF4632 YGL049C
BUR2
YLR226W
KAP95
YLR347C
MSH4
YFL003C
NAB3
YPL190C
NRD1
YNL251C
SCP160 YJL080C
SGV1
YPR161C
SRO9
YCL037
SRP1
YNL189W
AIR2
YDL175C

122
123
124
126
127
128
129
130
131
132
133

YRA2
NAB6
NUG1
SQS1
ASC1
DCP2
HRT2
MEX67
RIF2
GLE2
CSE1

YKL214C
YML117W
YER006W
YNL224C
YMR116C
YNL118C
YOL133W
YPL169C
YLR453C
YER107C
YGL238W
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CHAPTER 3
RESULTS
Identifying extragenic suppressors of the prp38-1 spliceosome maturation
mutant.
Spontaneous suppressors of the prp38-1 ts growth defect were selected
on YPD medium at the non-permissive temperature of 37 °C. Spontaneous
suppressors were found at a rate of roughly one per 1 X 106 cells plated. In total,
101 yeast strains were isolated that formed colonies after 2-3 days at 37 °C.
In principle, suppressor strains might harbor mutations within prp38-1 (i.e.,
intragenic suppressors) or within another gene (i.e., extragenic suppressors). To
define the subset of extragenic suppressors each strain was backcrossed to wild
type yeast and the resulting meiotic offspring scored for temperature sensitivity.
Unlinked extragenic suppressors will segregate from the original prp38-1 allele
and, as a consequence, ts mutants reappear in the meiotic offspring. Of the 101
suppressors analyzed this way, 11 are extragenic and the remaining 90 most
likely represent second site mutations within (or reversion of) prp38-1.
Extragenic suppressor mutations might result from loss of function and be
recessive in nature or from gain of function and be dominant alleles. To
distinguish between these possibilities, the extragenic suppressor set was mated
to a strain of opposite mating type bearing the original prp38-1 mutation (see
strain list in Materials and Methods). The resultant diploid strains are
homozygous for the prp38-1 mutation and heterozygous at the suppressor locus.
Each strain was tested for growth at the restrictive temperature. If the suppressor
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allele is dominant, then the diploid strain will form colonies at the temperature
non-permissive for prp38-1. In contrast, recessive suppressor mutations will be
masked in the heterozygous state and not support growth. All eleven extragenic
suppressor strains failed to grow at 37oC indicating that each resulted from a
recessive suppressor allele.
Since the suppressor alleles are recessive, candidate suppressor genes
could be identified by scoring for reacquisition of the ts phenotype after
transformation with a wild type gene copy. I used two of the “best” suppressors
(based on the colony size of the suppressed strain) for the initial gene isolation.
I transformed the suppressor strain M3 with a yeast genomic DNA library
prepared from wild type yeast (Figure 3.1). Transformants from a single-copy
(centromeric) plasmid library were selected by complementation of a plasmidlinked nutritional marker (URA3) at the permissive temperature (23°C) and then
screened by replica plating on nutrient rich medium at 37°C. In total,
approximately 30,000 plasmid transformants were screened. Two plasmids were
recovered from yeast that, by the replica plate assay, reacquired temperature
sensitivity.
While the yeast used for plasmid recovery clearly showed the ts
phenotype, it was possible that this was due to a spontaneous mutagenic event
in the transformant rather than the desired plasmid-linked event. In order to
address this, I recovered plasmids from yeast, amplified these in E.coli and re-
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FIG. 3.1 spp382-1 is a recessive, extragenic suppressor of the spliceosome
maturation mutant, prp38-1. Growth of wild type yeast (1, 5), an otherwise
isogenic prp38-1 (ts192) mutant (2, 6), and the suppressed mutant (3, 4) on rich
media after 3 days at the permissive temperature (23 °C) or two days at the
restrictive temperature (37 °C). In streaks 4-6, a centromeric yeast plasmid with
the wild type SPP382 gene (pSPP382) is co-expressed.
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transformed the each of purified DNA back into the original suppressor strain
(M3). Only one of the two recovered plasmids resulted in all the secondary
transformants showing the reacquisition of the temperature sensitive phenotype,
demonstrating a plasmid-dependent event. I noted that transformation of this
same plasmid into a wild type strain did not change its growth characteristics at
either 23 °C or 37 °C (Figure 3.1). Confirmatory results for plasmid linkage of the
ts phenotype were obtained by counterselecting for plasmid loss from the
secondary transformants by growth in the presence of the anti-metabolite, 5fluroorotic acid (Boeke, LaCroute et al. 1984). As predicted based on linkage,
plasmid loss resulted in colonies which were no longer temperature sensitive.
Thus, the identified plasmid (but not a control plasmid assayed in parallel) was
sufficient to block the recessive suppressor phenotype and thus contained a
yeast gene that might encode the wild type allele of the suppressor locus.
The candidate plasmid was sequenced to find out which chromosomal
region it contained. The DNA fragment had two ORFs (ATG17 and an unknown
open reading frame, YLR424w) from chromosome 12. ATG17 codes for a nonessential scaffold protein that plays a role in pre-autophagosomal structure
organization (Kabeya, Kamada et al. 2005) and seemed to be unrelated to
splicing. On the other hand, we and others had observed the YLR424w gene
product in splicing complexes (Gavin, Bosche et al. 2002); (Wang, Hobbs et al.
2003) making this the likely candidate. This gene was sub-cloned using PCR into
a centromeric plasmid. Transformation of this clone into the naïve M3 strain
resulted in reacquisition of temperature sensitivity (Figure 3.1). Confirmation that
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this was the suppressor-defined gene was made by linkage analysis which
established that the cloned DNA was inseparable from the original suppressor
locus (see Materials and Methods). I also sub-cloned ATG17 from the original
library plasmid using restriction enzymes and transformed into the original
suppressor strain. No loss of suppression was observed with this gene,
establishing YLR424w and not ATG17 as the suppressor gene.
Reduced Spp382p activity suppresses the prp38-1 defect.
SPP382 was reported as essential in the systematic analysis of yeast
gene function study (Giaever, Chu et al. 2002) but Spp382p’s role, if any, in
cellular splicing was undetermined. To investigate this, I tested a series of sitedirected mutations in residues conserved in the yeast, human, zebra fish, fruit fly
and nematode homologs (Altschul, Madden et al. 1997) for biological activity
(Figure 3.3 A). The plasmid borne spp382 mutants were scored for
complementation of the null spp382::KAN allele after plasmid shuffle removal of
a URA3-linked wild type copy of this gene (Figure 3.3 A). SPP382 encodes a
conserved 708 amino acid protein that contains a G-patch motif common to a
number of RNA binding proteins (Figure 3.2 B) (Aravind and Koonin 1999;
Silverman, Maeda et al. 2004; Tsai, Fu et al. 2005; Herrmann, Kais et al. 2007).
Changes in the G- patch domain either prove lethal (spp382-9 or spp382-10) or
impair growth (spp382-2 and spp382-3) consistent with this being a critical motif
(Fig 3.3 B and Table 3.1). A small deletion within the central domain results in a
tight ts mutant (spp382-5). Mutants bearing triple alanine substitutions near the
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FIG. 3.2. Alignments of the G-Patch and Spp382p protein. A. Alignment of
Spp382p homologs showing conservation of the protein across species. The
abbreviations used are C.e – Caenorhabditis elegans, D.r – Danio rerio, H.s –
Homo sapiens, D.m. Drosophila melanogaster, S.c - Saccharomyces cerevisiae.
B. Alignment of G-patch motif with the consensus below. The sequences are
named using the notation Protein name _ Species abbreviation_Gene Bank GI
(Gene identification number). Abbreviations used Sc - Saccharomyces
cerevisiae, Hs - Homo sapiens, Sp -Schizosacchromyces pombe, Ca -Candida
albicans, At - Arabidopsis thaliana.
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A
D.r.
60
H.s.
60
D.m.
45
C.e.
46
S.c.
31

1 MSMSHLYGRRGDEEEEDGVEIEKFEVSEWDLANEFNPDRRRYRQTKEEATYGIWAEQDSD
1 MSLSHLYRDGEGRIDDDDDERENFEITDWDLQNEFNPNRQRHWQTKEEATYGVWAERDSD
1 ---------------MSDNDYERFEITDYDLDNEFNINRPRGRQSRHQQIYGIWADDSEE
1 --------------MEDDDGRESFEINDMDLEYAMNPGGRRRFQNKDQATYGVFAPDSDD
1 -----------------------------MEDSDSNTDKKFFFKKRRIDSYNYSDEEDNN
* .

D.r.
106
H.s.
106
D.m.
105
C.e.
96
S.c.
60

:.:

*.

..:

61 DERPSFGGKR-------AKDYSTPVSFVSAGLRKTAAEEKAEREGSDDS-------DAEE
61 DERPSFGGKR-------ARDYSAPVNFISAGLKKGAAEEAELEDSDDEE-------KPVK
46 ESGGEGGTKRRGRAARKPKDYTMPVNFVAGGIQQAGKKKKKALQADDEKGSQKEGAEADQ
47 DDDEQGTSRG---PYKKRSKISAPMSFVSGGIQQGNKIDKDDPASLNLN-------LGGE
32 SSMNS------------DMTYTNDALKTSSGNAPTISKLTK------------------..

.

:

:.*

D.r.
146
H.s.
147
D.m.
165
C.e.
149
S.c.

107 APPPPRAAAPKKLQTGGSFKTSQR-FAGGIR-------------------TGQDLGNWEK

D.r.
201
H.s.
202
D.m.
223
C.e.
209
S.c.
117

147 HTRGIG--QKLLQKMGYVPGKGLGKNAQGIVNPIEAKLRKGKGAVGAYGSERTQQS---L

107 QDDFPKDFGPRKLKTGGNFKPSQKGFAGGTK-------------------SFMDFGSWER
106 GEESDDSAASGRPAFGQNDPGSSNSSSEEERPTLSRKQPSTTFQHRSHIASERNVGAWEQ
97 KKPKEDDEGSIQIDFDKRTKKAPKQNGAQVFAGMRSSANHG-------AADINQFGSWMR
------------------------------------------------------------

148 HTKGIG--QKLLQKMGYVPGRGLGKNAQGIINPIEAKQRKGKGAVGAYGSERTTQS---M
166 HTRGIG--AKLLLQMGYEPGKGLGKDLQGISHPVQAHVRKGRGAIGAYGPETAASIGGKT
150 GDGNSNKIMKMMQAMGYKPGEGLGAQGQGIVEPVQAQLRKGRGAVGAYGKESTATGPKFG
61 -TYGIG--AKLLSSMGYVAGKGLGKDGSGITTPIETQSRPMHNAGLGMFSNTNSSNYHSE
. .

D.r.
254
H.s.
254
D.m.
281
C.e.
269

*::

*** .*.*** : .**

*:::: *

:.*

.

:

202 QDFPVVDSEEEEEEEFQKELGQWRKEPGT-------AKKKPKYSYRTVDDLKAHGTRANM
203 QDFPVVDSEEEAEEEFQKELSQWRKDPSG-------SKKKPKYSYKTVEELKAKG-RISK
224 NKSIKVDEDVREAKEFKDQLNKWRKGSAGGAE--PMERQGKRYYYKSVEEVIAKGHTSGH
210 ESAADAQKRMAQEGTSSRPTNDDQEKSGLKIKGSWKKSQTVKTKYRTIEDVMEEGMSASR
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S.c.
170

118 NEDYLSSEDEVVEGIEQVKFNKTSTEVLG-------EALLNDSGDMTIVRTLRELRLAGV
:.

D.r.
307
H.s.
313
D.m.
338
C.e.
318
S.c.
218

..

.

.

282 LLSEKLSKKLGNVRVIDMTGPEKRVLSGYHALGQAKITPEETLYDTEATEKGS---APAC
270 PASHQQSQQYSNIKVIDMTGKQQKIYSGYDSFSMKTRSEYDTVDDEERT----------171 QLPESILKELDPLNAVPKPKKDVVVEILQELLGIEKSLEAIRQR------------TSPL
:

:..:

.

:

:

:.

308 GFALPELEHNLKLLIELTEQDILQSARLLQHEKDTVVTLTHESDALQVRLAEEEETLGRL
314 GFALPELEHNLQLLIDLTEQEIIQNDRQLQYERDMVVNLFHELEKMTEVLDHEERVISNL
339 VFAMPELTHNLQLLVSQCEQQIIAIDNQERECSSQQAALESEHRKLEEIVQLERNHIRTL
319 VFDVPELIHNLNLLVDLTEEGIRRSNQQLISLKDQTTALEYDLQQVQKSLGTEEQEAQHI
219 EVQVKEYYGQERLLSELEVTLRDESKHVSLYDKIGAILKLSDDELIDRLTSCLLRKELLI
: .** .

.

:

:

.

:

368 EQVMSLVERFEAGDKEGDP-ALSLQECAKIFEQLQTEFYQEYKTMGLGDLAVSVVHPLLK
374 SKVLEMVEECERRMQPDCSNPLTLDECARIFETLQDKYYEEYRMSDRVDLAVAIVYPLMK
399 EESLERVERLIDNPD------LSLPQAERLFRELLVDYAAEFHEFGLADLAAGVIAPLLK
379 KDVYELIDGFSSNRSP------SMEECQELFRRLRSEFPHEYELYSLETVAIPTVLPLIQ
279 EFDLDHLEKPNDILD------------ELTQIIELLAYRMDTTSKFLNRTQTTIFKVIYP
.

D.r.
480
H.s.
487
D.m.
505
C.e.
492
S.c.
372

::

255 KLTAPQ-KELSQVKVIDMTGREQKVYYSYSQISHKHNVPDDGLPLQSQQLPQSGKEAKAP

. : *

D.r.
426
H.s.
433
D.m.
452
C.e.
432
S.c.
326

..

255 SMSRPA-GELAQVKVIDMTGREQKVYNSYSHMSQKHSVP------EEAPLSVSTREQKSS

.
D.r.
367
H.s.
373
D.m.
398
C.e.
378
S.c.
278

.

. ::

.

:

:

.

:

427 EKLRNWDPLKDCSDGLEEVGQWRAILESTL------SLHSGPDTTNMDPYHRLIWEVWVP
434 EYFKEWDPLKDCTYGTEIISKWKSLLENDQ------LLSHGGQDLSADAFHRLIWEVWMP
453 RELVQWQPLENPTEPLPLIKKWRGMLQQGD------AAEQQPR-NVFDPYSSLIWAGVMP
433 KYFVAWKPLEDKNYGCELISTWRDILDDSKNGRKMTFGHNKTKGDEIRAYDRIIWEGILP
327 KLKKFWEGFDMTKSKIDSAITLLLDFQQVLS--------------FIGCKEHIMEEFVYP
.

*. :.

.

::.
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::

*

D.r.
537
H.s.
544
D.m.
562
C.e.
550
S.c.
432

481 VMRTCVSQWQP-RNVGPMVD--CVECWAPVLPLWILDHVLEQLIFPRLQREVDNWNPLTD
488 FVRNIVTQWQP-RNCDPMVD--FLDSWVHIIPVWILDNILDQLIFPKLQKEVENWNPLTD
506 SFRSSAAAWQP-KEHPPMAS--LLDAWAPLLPSWVLDSVLEQLVLPRLVAGVQEWDPLTD
493 SIRRACLQWDPSTQMHEMIE--LVEQWIPLLSAWITENILEQLVVPKIAERVNQWDPMTD
373 KLLQELDNWELHDEVDHVSPRIWVLDFMVLIDDKIKDTIVDKIEAKFFAYCKNWYHRESF
.

D.r.
596
H.s.
603
D.m.
622
C.e.
609
S.c.
492

*:

:

:

:

::

: : :::::

:

563 TVPIDSWVLPWHAILGSKLEEAVYPQIRSKLGIALRAWSPHDRSARAMLTPWQKAFPEEE
551 EIPIHEWLVPWLVLLGDRIQT-VMPPIRQKLSKALKLWDPMDRSALETLRPWQNVWSAAT
433 CITNSDIIFIKELICERRYYKILCKEFLPKFLDELWERHNDPIYELEDWKEKQEWKEKDS
. :

:

:

:

:

*:

*

:.

597 WEAFMVKNIVPKLALCLGELVVNP-HQQLLDPFNWVMDWECMLSVSSMVGLLDKNFFPKW
604 WEAFMVKNIVPKLGMCLGELVINP-HQQHMDAFYWVIDWEGMISVSSLVGLLEKHFFPKW
623 MQEFLQRYIVPKLQATLGELIIIP-MHQDLELWQQVWEWHELIDPMYMAQLLDRHFFPRW
610 FSAFIAQNIVPKLGVALDTMELNPTMNPEYPEWTACMEWLEFTHPDAIANIVTKYFFPRF
493 GFFYFMKKLRSYTHYFHPKQYELMMRGTFNNINKILYQWHLYS---TVEDLHKSKWWLNW
:*

:

:

:: .:

656 LQVLCSWLSN-NPNYEEITKWYLGWKGLLSENLLSHPLVKEKLNEALDIMNRAVASGLGG
663 LQVLCSWLSN-SPNYEEITKWYLGWKSMFSDQVLAHPSVKDKFNEALDIMNRAVSSNVGA
682 MQVLVVWLNQ-SPDYAEISRWYTGWKSMLSEPLLREPSVKEHLRRALEIMHRASDTLLQP
670 YNCLCLWLDSPGVDYNEVKRWYGSWKARIPQVLVNYPTVNENLRRSMIAIGRSLQGEKVG
550 LMNTVFEHSLPTEIELSEIRKSYNIFAMSHRYHLDKSTLDEDFDLRQGLRNLMETQVIDD
.

D.r.
774
H.s.
779
D.m.
775
C.e.
766

: :.

545 TVPIHSWIHPWLPLMQARLEP-LYSPIRSKLSSALQKWHPSDSSAKLILQPWKDVFTPGS

:: : : .
D.r.
714
H.s.
721
D.m.
740
C.e.
729
S.c.
609

:

538 TVPIHSWIHPWLPLMQTRLEP-LYAPIRSKLAHALQRWHPSDSSARLILQPWRDVFTPGA

:.
D.r.
655
H.s.
662
D.m.
681
C.e.
669
S.c.
549

:

.

:

.

.

:

. :.:.:

715 YMQPGARENIAYLIQTERRKDFQCELQPERREVDNSATRPPGMAAVPASVPTNFKDLVQA
722 YMQPGARENIAYLTHTERRKDFQYEAMQERREAENMAQR--GIGVAASSVPMNFKDLIET
741 TVTPTPPP-------------------------PVPPAPVIMMDLIHPPAQLEFKELVSQ
730 GLQATPIAPMAP-----------------------PPPMAPHFTQAAPVQKLSLKEIIEY
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S.c.
643

610 ISQSEQEP--------------------------TYTVQNIPLGKVSSSFKDVVEDYCLE
.

D.r.
832
H.s.
837
D.m.
835
C.e.
826
S.c.
703

.

.

.::

775 KAEENGIVFMPLVAKRHMGKQLFTFGRIVIYIERGVVFVQGE--KTWVPTSLQSLIDMAK
780 KAEEHNIVFMPVIGKRHEGKQLYTFGRIVIYIDRGVVFVQGE--KTWVPTSLQSLIDMAK
776 QCADLGIIFAPLPGRREMGKQIYRVGKLFCYIDRHVCMVSDGSFSNWKPVSLNHLLERSQ
767 TAGKNGFTYHPQKDRYKDGRQVFWFGALSIYLDSEMVYVMDPIEFVWRPSGLNELIQMAQ
644 KGYLISKIPNRYTQLPYGRDQDCIVPLFEIRNGKKKMEVALKHDILWVEDSSGTFKPIYL
.

D.r.
H.s.
D.m.
C.e.
S.c.

:

*

.

--------836 TGIL- 839
827 GAQG- 830
704 WALDL 708
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:

*

*

.

:
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C-terminus (spp382-7 or spp382-8) show wild type growth whereas a nearby
frameshift mutation results in slowed growth (spp382-6). A GAL1 driven N
terminal deletion (spp382-4) that shifts the translational start to codon 34,
supports efficient cell growth on galactose based medium (Fig 3.3 B and 3.3 C).
I noted that the spp382-1 mutant grows less well when expressed from
this plasmid than when expressed from its normal chromosomal locus. I
speculated that this might be due to a too-short 3’UTR in the plasmid construct.
To test this, I re-created the construct with a longer 3’ UTR (original clone was
2527 base pairs (bp) ending at the stop codon while the 3’ UTR clone is 2677 bp
with additional 150 bp downstream of the stop codon) and this strain grows as
well as the chromosomal integrant (Fig 3.3 C). This observation suggests that the
too-short 3’ UTR exacerbates the spp382-1 growth defect and may contribute to
the weaker growth of the other spp382 mutants. However it should be noted that
the short 3’UTR by itself is not particularly inhibitory, since the spp382-7 and
spp382-8 clones grow as well as wild type.
Next the newly created spp382 mutants were tested for the ability to
suppress the prp38-1 defect. The plasmid based spp382 mutants were
transformed into a prp38-1 strain with a chromosomal deletion of the SPP382
locus (i.e., spp382::KAN) and a URA3-linked wild type allele of SPP382. The
spp382 mutant alleles were checked for suppression by growing the strain at
37 °C after removal of the URA3-linked SPP382 by plasmid shuffle. Suppressor
alleles were found distributed throughout the coding sequence (i.e., spp382-1,

48

FIG. 3.3 Spp382p is essential for cell viability. A. PCR-based mutagenesis
was targeted to conserved regions of Spp382p (based on UniProtKB entries:
Q06411, Q9UBB9, Q6DI35, Q9NHN7, and Q17784). Panel A shows the amino
acid changes and numbered coordinates on the 708 amino acid protein. B.
Growth assays performed in yeast with the indicated spp382 allele at 23 °C and
at 37 °C. C. Growth assay showing the effect of shortened 3’ UTR. The growth of
a plasmid borne spp382-1 with the short 3’ UTR (spp382::KAN, p-spp382-1), a
plasmid borne spp382-1 with elongated 3’UTR (spp382::KAN, p-spp382-1 +
3’UTR), and that of a chromosomal spp382-1 strains at 23 °C and 37 C
compared to wild type and prp38-1 mutant. It should be noted that the figure B
and C are a composite of multiple plate cultures incubated at the indicated
temperatures for identical periods of time.
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Table 3.1 Suppression by titration of an essential splicing activity. Visible
colonies from an otherwise inviable prp38-1mutant were indicative of
suppression (Yes) while no growth indicates no suppression (No). NA means not
applicable. * indicates that this allele was expressed with the GAL1 promoter, all
other alleles were expressed with the SPP382 promoter. ** indicates the strain is
lethal.

Allele

prp38-1 suppression

SPP382

NA

prp38-1

NA

spp382-1

Yes

spp382-2

No

spp382-3

No

spp382-4*

Yes

spp382-5

Synthetic Lethal

spp382-6

Yes

spp382-7

No

spp382-8

Yes

spp382-9**

NA

spp382-10**

NA
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spp382 -4, spp382 -6 and spp382-8). The tightly ts allele, spp382-5, is lethal in
the prp38-1 background. None of the mutations were found to suppress a lethal
prp38::KAN null allele and similarly the prp38-1 mutation does not rescue the
lethality of the spp382-9 or spp382-10 mutations (Table 3.1).
Spp382p is required for splicing and for normal intron metabolism.
Incomplete repression of transcription prevented the use of
GAL1::SPP382 to assess the cellular role of Spp382p in splicing (Fig 3.4A). But
the metabolic depletion can be achieved using the functional GAL1::spp382-4
allele which shows time dependant inhibition of splicing and growth (Fig 3.4 B
and data not shown). Under this condition, no change is observed in the
intronless ADE3 transcript or the mature rRNA (Fig 3.4 B).
The level of splicing inhibition observed with the spp382 point mutants
was shown to parallel the growth impairment (Fig 3.5). Mutants with strong
growth defects (spp382-1, spp382-2, spp382-3, spp382-5, and spp382-6) show
significant splicing inhibition, especially at higher (37 °C) temperature. Mutants
that support robust growth show little splicing inhibition (e.g., spp382-7, spp3828).
Mutations in some splicing factor genes, especially those splicing factors
involved in spliceosome disassembly, accumulate excess levels of excised intron
(Arenas and Abelson 1997); (Martin, Schneider et al. 2002). It is believed that the
residual bound splicing factors inhibit the turnover pathway. I decided to probe
whether excess intron accumulates in the spp382 mutants by probing my
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FIG 3.4. Spp382p is required for splicing. Northern analysis of splicing
inhibition with yeast that express the nutritionally regulated GAL1::SPP382
(Panel A) or GAL1::spp382-4 gene (Panel B) (T=0) and 4 to 20 hours after
transcriptional repression by glucose. Yeast that express the wild type allele
(SPP382) and were assayed in parallel after growth in galactose (T=0) or
glucose (T-=20). The positions of the intronless ADE3 mRNA and the RPS17A
pre-mRNA and mRNA and the mature rRNA are shown to the left.
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northern blot with the ACT1 intron (Fig 3.5, lower panel). For unknown reasons,
ACT1 is more sensitive in this assay than RPS17A. I quantified the intron
accumulation using ImageQuant software. The intron accumulation is greatest
with the central domain mutants, spp382-1(9 fold more at 37 C) and spp382-5
(15 times more than control at RT and 23 fold more at 37 °C) and with one of the
G-patch mutants, spp382-3 (9 times increased at RT) when compared with the
wild type. spp382-6 only accumulates about 2 times more intron, when compared
with the control. There seems to be no simple correlation between intron
accumulation and suppression. For instance, while spp382-1 accumulates
excess intron and suppresses prp38-1, spp382-3 and spp382-5 accumulate
much more excised intron but do not suppress prp38-1. spp382-6 and spp382-8
suppress prp38-1 but accumulate little excess intron. While excess intron
accumulation presumably relates to splicing impairment, I note that even this is
not a simple relationship. For instance, for spp382-3 intron accumulation is more
evident at 23 °C when there is little or no splicing impairment. However, at 37 °C
where splicing inhibition is seen, intron accumulation is not observed.
Presumably, the spp382-1 suppressed prp38-1 strain grows better
because splicing efficiency is improved. To address this, I compared splicing in
the suppressed strain to the wild type and the mutant prp38-1 parent. Although
the mRNA to pre-mRNA ratio (an established measure of splicing efficiency
(Rymond, Pikielny et al. 1990) reproducibly increases, the enhancement in
splicing is very subtle when assayed with either RPS17A or RPL28. Based on
this, it seems that neither ribosomal protein is likely limiting for growth under the
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FIG 3.5. Spp382p is required for normal intron metabolism. Northern analysis
done with wild type yeast, the prp38-1 mutant, and the non-lethal spp382
mutants assayed at room temperature (-) or after 2 hours at 37 °C (+). The lower
panel shows accumulation of the ACT1 excised intron RNA.
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Intron accumulation in

25 °C

37 °C

WT *

1X

1X

Prp38-1

1X

1X

Spp382-1

3X

9X

Spp382-2

1X

1X

Spp382-3

9X

1X

Spp382-5

15X

15X

Spp382-6

2X

2X

Spp382-7

1X

1X

Spp382-8

1X

1X

* The intron accumulation is compared to that seen occurring normally in wild
type (default (1X))

58

FIG 3.6. Splicing efficiency of the spp382-1, prp38-1 strain. Splicing of the
prp38-1 mutant and the prp38-1, spp382-1 double mutant at 23 °C and after 2
hours at 37 °C (+). The 25S and 18S rRNA bands are presented as
normalization controls for RNA loading and transfer.
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conditions of assay (Fig 3.6), although it is possible that modest decreases to
many ribosomal protein genes combine to impair growth.
To find out at which step splicing is blocked after Spp382p inactivation, I
performed primer extension analysis. RNA was extracted from strains
transformed with a well established reporter gene, HZ18, that contains the intron
and flanking exon sequences of the ribosomal protein, RP51A (renamed
RPS17A) fused to lacZ (Teem and Rosbash 1983). Primer extensions were
carried out using an oligonucleotide complementary to exon 2, RB1 (Rymond,
Pikielny et al. 1990). The primer extension products generated by RB1 include
pre-mRNA, lariat intermediate and spliced message (the heterogeneous mRNA
population is because of multiple start sites of the CYC1 promoter). The primer
extension analysis shows accumulation of pre-mRNA rather than the lariat
intermediate in the mutant spp382-1 background, even at room temperature (Fig
3.7). Similar results were obtained for spp382-6 (Fig. 3-7 and for spp3822,spp382- 3 and spp382-5 (data not shown). Thus, while reported dispensable
for splicing in vitro (Chan, Kao et al. 2003), Spp382p is essential for first
transesterification step in vivo.
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FIG 3.7. Spp382 mutants inhibit the first step of splicing. Primer extension
analysis of RNA isolated from spp382 mutants and a wild type strain using an
exon 2 oligonucleotide complimentary to a RPS17A reporter. The position of
cDNA molecules corresponding to unspliced fusion transcripts (HZ18), spliced
fusion message, lariat intermediate and spliced endogenous message is
indicated to the right.
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Extracts from yeast depleted of Spp382p fail to assembly complete
spliceosomes.
Spp382p might function directly in splicing or act indirectly, for instance, by
stabilizing poorly spliced pre-mRNAs. To investigate the impact of Spp382p
depletion on the splicing apparatus, splicing complexes assembled in vitro on
biotin-substituted RPS17A pre-mRNA were affinity-purified by streptavidinagarose chromatography and assayed for snRNA content. As seen in Figure 3.8,
with the wild type extract, the earliest complexes recovered contain U1 and U2
snRNAs and some U4, U5 and U6 snRNAs. As the assembly progresses, the
relative yields of U5 and U6 snRNAs increase. The expected release of U4
snRNA (Xie, Beickman et al. 1998) from the spliceosome can be seen as a time
dependant decrease in the recovered U4 snRNA relative to the U6 snRNA
(compare lanes 9,12). Note that non-specific association of unmodified (i.e.,
biotin-free) pre-mRNA or snRNAs with the streptavidin agarose matrix is
insignificant (lanes 6 and 13). Metabolic depletion of the essential Rcp10 protein,
a protein we recently identified as an essential U2 snRNP SF3b component
(Wang, He et al. 2005), blocks assembly after U1 snRNP addition showing
spliceosome assembly arrest at the commitment complex stage (lane 7).
Metabolicl depletion of Spp382p (see Material and Methods) allows the U2
snRNP to be added (i.e., prespliceosome formation) but assembly arrests at that
point. Note that the total snRNA levels remain comparable to wild type (lane 1
and 8) and hence snRNAs are not degraded in the absence of Spp382p. This
indicates that, in extracts from cells depleted of Spp382p, impaired U4/U6.U5 tri-
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FIG 3.8. Removal of Spp382p blocks splicing complex assembly at the
prespliceosome stage. Splicing complexes assembled on biotin substituted
RPS17A pre-mRNA for the indicated times were affinity purified by streptavidin
agarose chromatography and assayed for snRNA content (arrow heads) by
northern blot. Total = Total, unselected extract RNA; no biotin = parallel reaction
conducted with pre-mRNA lacking biotin.
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snRNP addition limits spliceosome assembly. This block might result from
reduced U4/U6.U5 snRNP assembly or from reduced U4/U6.U5 snRNP affinity
for the prespliceosome. In either case, genetic depletion of Spp382p reproducibly
results in splicing-inactive extracts that fail to assemble splicing complexes
beyond the prespliceosome stage.

Spp382p is not an integral snRNP protein but its depletion inhibits stable
tri-snRNP formation in vivo.
To investigate whether Spp382p is associated with the major spliceosomal
snRNP particles, I first looked for evidence of co-sedimentation in a 15-45%
glycerol gradient. I checked alternate fractions of the yeast Spp382-TAP extract
(an epitope-tagged derivative) for the presence of Spp382-TAP and the splicing
associated snRNPs. I note that the SPP382-TAP is expressed from its native
promoter at its original genetic locus and therefore is likely present at normal
levels. 15 µl of extract from the alternate fractions were run on an SDS protein
gel and probed with an antibody that binds to the TAP epitope. At the same time,
RNA isolated from alternate fractions was resolved on denaturing polyacrylamide
gel and hybridized with snRNA-specific probes to see the distribution of snRNPs
across the gradient. Most of the Spp382-TAP was found in fractions 3-9 that
include the bulk of cellular proteins (mostly fractions 1-7), well separated from the
majority of the snRNP complexes. I note that the Spp382-TAP profile does
overlap the free U6 snRNP and the U4/U6 di-snRNP (Fig 3.9, Panel A and Panel
B). While not shown here, the large U1 and U2 snRNP
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FIG 3.9. Spp382p's relationship to the tri-snRNP. A. Extract from cells
expressing Spp382-TAP was fractionated on a 15 to 40% glycerol gradient and
odd numbered samples assayed by western blot an anti -TAP antibody (lanes 123). The lanes marked "Total" show un-fractionated extract.
B. Northern analysis of snRNAs present in the glycerol gradient fractions.
C. Northern analysis of snRNAs recovered by immune precipitation with Spp382TAP, untagged extract, and the U5-specific Aar2-TAP.
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particles broadly resolve over the deeper half of the gradient (see Fig. 3.9,
below). Based on this, I conclude that under these low stringency salt conditions
(150mM NaCl concentration) much of the Spp382p likely exists independent of
the major snRNP complex forms driving spliceosome assembly (i.e., U1, U2,
U4/U6.U5 snRNPs).
To further investigate whether Spp382p associates with the spliceosomal
snRNPs, I next tested whether the U1, U2, U4, U5, or U6 snRNAs co-purify with
Spp382-TAP affinity purified on IgG agarose. Northern blot analysis of the
recovered RNA (Fig. 3.9 C) shows that Spp382 precipitates mostly the U5
snRNA. While typically 35-50% of the cellular Spp382p could be recovered, no
more than 10% (and generally less) of the U5 snRNA was recovered, indicating
that Spp382p is unlikely to be a core U5 snRNP protein. This is consistent with
previous reports on the yeast U5 snRNP composition (Stevens, Barta et al.
2001). Aar2-TAP, a component of the U5 snRNP and the gene representing the
second suppressor identified in my screen (see below), also precipitates U5
snRNA. as well as U1 snRNA as shown previously reported by Fabrizio and
Luhrmann (Gottschalk, Kastner et al. 2001). Background binding to the protein A
resin is negligible under these conditions (No Tag lane).
I next wanted to address whether Spp382p depletion alters the snRNP
composition of a cell. Extracts prepared from yeast with a normal Spp382p
content and from a strain metabolically depleted for Spp382p (by glucose
repression of GAL1-spp382-4) were resolved by glycerol gradient fractionation
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and then assayed by northern blot as described above (Fig 3.10) Unfractionated
RNA present in the extract is marked as “Total”.
With wild type extract, the free U6 snRNP migrates in the top of the
gradient (fractions 3-5, panel A), followed by the U4/U6 di-snRNP complex (lane
7-11, A). The U5 snRNP fractionates across the gradient whereas the tri-snRNP
is found near the bottom of the gradient (fractions17-21, A). The final fraction
contains, in addition to tri-snRNP particles, endogenous spliceosomes and
insoluble aggregates. In contrast to the wild type extract, there is little tri-snRNP
present after Spp382p depletion (lane 17-21, B) and the relative amount of
U4/U6 complex increases (compare fractions 7-11 in A and B). The asterisk
indicates the position of what is likely free U5 snRNP although the cofractionation of significant amounts of (especially) U6 and U2 may indicate that
this is a more complex mixture. Note that the total snRNA levels are comparable
in the two extracts (Total, A and B) and hence failure to observe much stable trisnRNP is not a consequence of snRNA instability. The increase in U4/U6 snRNA
levels along with decreased tri-snRNP suggests a defect in the assembly or
recycling of snRNP particles for instance, the U2/U5/U6 post splicing complex
which might be represented in lane 13.

72

FIG 3.10. Depletion of Spp382p inhibits stable tri-snRNP formation. Cell
extracts of a wild type strain (panel A) or GAL1::spp382-4 strain (panel B) grown
on glucose (to effect metabolic depletion of Spp382p) were layered onto a 1545% glycerol gradient and the snRNP complexes resolved by centrifugation.
RNA was isolated from odd numbered fractions and assayed by northern blot for
snRNP composition using snRNA specific probes (lanes 1-23 in panel A and B).
Lanes marked "Total" refers to un-fractionated RNA present in the extract. The *
in Panel B represents the position of what may be the free U5 snRNP or an
aberrant from of the spliceosome (U2, U5, U6).
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I also monitored snRNP assembly by running native polyacrylamide
gels with extracts that contain Spp382p or are depleted of the protein (see
Material and Methods for details). After transfer, the blot was hybridized with
radiolabeled snRNA-specific probes. Consistent with the glycerol gradient
fractionation results, when Spp382p is depleted in vivo, tri-snRNP assembly is
affected. With U5 snRNA specific probe, the Spp382p depleted lane shows little
or no tri-snRNP, compared with the non depleted or wild type control (Fig 3.11,
Panel A). When probed with either U5 or U6 snRNA specific probe, an aberrant
complex (see * in the Figure 3.10, migrates more slowly compared to tri snRNP)
is seen (Fig 3.10, Panel B). I also detected U2 in this complex when I probed the
blot with a U2 specific probe (data not shown). This appears to be a stalled late
spliceosome, with the U2.U5.U6 snRNAs. Taken together this indicates that
depletion of Spp382p negatively affects tri-snRNP assembly or stability.

Spp382p binds spliceosomes including defective complexes that lack the
5’ exon.
To investigate whether Spp382p associates with the splicing complex, I
affinity purified a Tap-tagged derivative (Spp382-TAP) by IgG-agarose selection
from in vitro assembled splicing complexes and assayed for co-recovery of the
uniformly labeled substrate. As controls, extracts were also assayed from cells
that express Prp19-TAP, a protein that stably binds the spliceosome right before
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FIG 3.11. SnRNP profile of Spp382p depleted extracts. Splicing extracts were
prepared from wild type cells or from GAL1::spp382-4 strain grown on glucose
(to effect metabolic depletion of Spp382p). The extracts were analyzed by native
gel electrophoresis and northern blotting. The position of the tri-snRNP
(U4/U6.U5), disnRNP(U4/U6) and free U6 are indicated. The * denotes a slowly
migrating complex enriched after Spp382p depletion that might represent an
aberrant spliceosome.
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or concurrently with U4 loss, and BBP-TAP, a protein that associates transiently
with the spliceosome early in assembly.
The Prp19-TAP protein pulls down the lariat intermediate and excised
intron and free 5’ exon in similar relative amounts compared with the input
sample (Fig. 3.12, panel A, lanes 13-18). A little unprocessed pre-mRNA is also
recovered but no spliced mRNA is found associated with the Prp19-TAP,
consistent with the very rapid dissociation of mRNA from the spliceosome. Only a
minor amount of pre-mRNA, but no lariat intermediate or excised intron is
recovered with a TAP tagged branchpoint binding protein (BBP). As expected
with a protein that binds early and transiently to the splicing apparatus, the premRNA signals decrease to background (WT no tag) with BBP-TAP, late in the
splicing reaction (Fig. 3.12, panel A, lanes 7-12).
Both lariat intermediate and excised intron are recovered with Tap-tagged
Spp382p (Fig. 3.12, panel A, lanes 1-6). When compared to the input RNA, the
recovery of excised intron appears favored, especially late in the splicing
reaction. Some unprocessed pre-mRNA but little or no spliced mRNA is found in
the bound fraction. Unlike Prp19-TAP, little or no 5’ exon signal is detected in the
Spp382-TAP IgG pellet, even with a four-fold increase in exposure time (Fig.
3.12, panel A, compare lanes 4-6 and 28-30). The absence of the 5’ exon is
unexpected since this is not a natural form of the splicing complex.
To further investigate the binding of Spp382p to “5’ exonless” complexes, I
assayed a substrate truncated just upstream of the 3’ splice site (Fig. 3. 12, panel
B) for which the lariat intermediate and free exon accumulate as terminal
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products (since no downstream exon exists). Nonspecific RNA binding to the
resin is negligible (lanes 11-12) and, as before, lariat intermediate and 5’ exon
are recovered from the 30 minute splicing reaction with Prp19-TAP in amounts
that approximate the 2.5:1 signal ratio expected based on nucleotide content
(lanes 9, 10). With Spp382p, lariat intermediate is recovered as is some premRNA, but, as before, little or no free 5’ exon is found in the IgG pellet (lanes 1
and 2).
The trivial possibility that Spp382-TAP IgG selection causes release of the
upstream exon appears unlikely as free (i.e., non-spliceosomal) 5’ exon is
resolved by glycerol gradient fractionation prior to selection (Figure 3.13 A). In
addition, lariat intermediate molecules are preferentially recovered from lighter,
possibly incomplete spliceosomal fractions (Fig 3.13, panels A and B). I note,
however, that when complexes are first fractionated by glycerol gradient
sedimentation more 5’ exon is recovered with Spp382-TAP. The reason for this is
unknown.
Less pre-mRNA is recovered with Spp382-TAP or with BBP-TAP than
with Prp19-TAP (Fig. 3.12 B, compare lanes 2, 4, 10 with lane 12). Although the
amount of pre-mRNA recovered with the TAP tagged proteins is low, it appears
to be specific. For instance, the recovery is enhanced (and splicing blocked) in
extracts where the BBP-TAP commitment complex is stabilized by
oligonucleotide-directed RNase H digestion of U2 snRNA (compare lanes 4 and
6 in Fig 3.12 B, in the lower exposure detail). No change is observed if a control
oligonucleotide is used (Fig 3.12 B lane 8). For Spp382-TAP, the pre-mRNA
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recovered comes exclusively from the spliceosomal 40-50S fractions even
though most of the pre-mRNA remains in the unassembled pool (Fig 3.13 panel
A and B) again consistent with recovery from splicing complexes.
These results suggest that Spp382p may bind weakly or transiently to a
subset of spliceosomal complexes, including complexes that have lost the 5’
exon. To investigate the role of the upstream exon in sample recovery, I repeated
the splicing reactions with RPS17A substrates where the 38 nucleotide 5’ exon
was lengthened (+13) or shortened by 16 or 25 nucleotides (Fig. 3.12 C). As
measured by phosphorimaging, the lariat intermediate to fully excised intron (L/I)
ratio, a measure of step two splicing inhibition, increases ~1.2-fold between the
shortest and longest substrates (lanes 1–4). In contrast, this ratio more than
doubles in the Spp382-TAP-recovered pool (lanes 5–8). This greater than
proportionate increase reinforces the belief that a distinct subset of lariat
intermediates, specifically the defective complexes, are being selected by
Spp382-TAP. I note that based on the yield of RNA found in the IgG pellet, such
complexes represent a very small percentage of lariat intermediate, less than 5%
of the lariat intermediate present in the splicing reaction.
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FIG 3.12. Spp382p binds defective spliceosomes. A. In vitro pre-mRNA
splicing with 32P-labeled RPS17A pre-mRNA processed for the indicated times
under standard conditions (Pikielny, Rymond et al. 1986) and assayed by
denaturing PAGE before (Total) or after IgG agarose selection (IgG). The detail
(det.) to the right shows a 4-fold overexposure of the first 6 lanes to highlight the
absence of upstream exon with IgG-agarose selected Spp382-TAP. The
positions of the unprocessed pre-mRNA (P), lariat intermediate (LI), excised
intron (I), spliced mRNA (M) and free upstream exon (5’E) are indicated.
B. In vitro splicing and RNA recovery with a 3’ splice site truncated RPS17A
mRNA blocked for the second step of splicing. Alternating lanes show the total
processed RNA (T) and the IgG agarose pellets (P) after 30 minutes of splicing.
The asterisk shows the position of linearized lariat intermediate sometimes
observed under these conditions. The detail below (det.) shows a 4 fold
underexposure of the corresponding pre-mRNA region to highlight the enhanced
substrate recovery by IgG agarose after U2 snRNA degradation.
C. Extended (+13) or shortened ( 16, 25) 5' exon RPS17A substrates were
spliced for 30 min under standard conditions and then assayed for products
before (lanes 1–4) or after (lanes 5–8) Spp382-TAP selection. The 5' exons
(below the bar) were run on a second gel to resolve the smaller fragments.
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FIG 3.13. Exon release occurs before Spp382-TAP selection in lighter
spliceosomal complexes. After 30 min of splicing with the 3’ splice site
truncated RPS17A mRNA in the Spp382-TAP extract, complexes were resolved
by velocity sedimentation in a 15-40% glycerol gradient. A. Alternate fractions
were assayed on a denaturing polyacrylamide gel and the positions of the
splicing precursor and intermediates are noted on the left.
B. The indicated gradient fractions were pooled, selected by IgG agarose, and
resolved by denaturing PAGE as total, unselected RNA (T), or RNA enriched in
the IgG agarose pellet (P).
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Genetic interactions of Spp382p.
Chen et. al showed that Prp43p requires Spp382p for intron release from
the spliceosome in vitro (Chan, Kao et al. 2003). This observation raises the
interesting possibility that the suppression of prp38-1 by mutants of spp382
results from impaired spliceosome dissociation by Prp43p. If this is true, then the
prp38-1 stalled spliceosome must retain partial residual activity since
suppression of a fully inactive complex would not be possible by this mechanism.
Also one predicts that spp382-based suppression would not be restricted to
prp38-1 but would extend to other defects in the spliceosome assembly pathway.
Consistent with the first prediction, I find that overexpressing prp38-1p (the
mutant protein) also suppresses the prp38-1 strain similar to the previously
characterized dosage suppressor, SPP381 (Fig 3.14, 37 °C panel). This confirms
that the prp38-1p spliceosomes have residual activity.
To test the second prediction, I scored additional conditional mutations
within the components of the splicing enzyme for suppression. Like prp38-1,
prp38-2, another mutant allele of PRP38 (Xie, Beickman et al. 1998), is also
suppressed by spp382-4 (data not shown). I also tested spp382 mutants’ ability
to suppress various other splicing mutants. I choose mutants which blocked the
spliceosome at distinct steps in assembly, catalysis and disassembly. I find that
the ts prp8-1 mutant (blocked before activation) is suppressed by spp382-4 (Fig
3.14) and also by the spp382-1 and spp382-6 alleles. Spp382-6 also suppresses
prp19-1, a single point mutant of Prp19p, which binds the spliceosome after or at
the same time U4 snRNA leaves (Chan and Cheng 2005). No suppression is
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observed with splicing mutants, prp4-1 (spliceosomes in mutants blocked prior to
catalysis)(Fig 3.15), prp3-1 (mutants locked at pre-spliceosome stage), prp61(mutants blocked at pre-spliceosome stage), rds3-1(mutants blocked prior to U2
snRNP binding), (Wang and Rymond 2003) prp39-1(U1 snRNP binding fails in
mutants), (Lockhart and Rymond 1994) when tested with either spp382-4 and
spp382-6. Likewise, no suppression was observed with mutant derivatives of two
DExD/H-box proteins encoded by prp16-1 (mutants blocked at step 1) and
prp22-1 (mutants fail to release message). Finally, in support of a functional
association of Spp382p and Prp43p, I find that the prp43R424A mutation (Martin,
Schneider et al. 2002) is synthetically lethal with the spp382-4 and spp382-6
(data not shown).
I also initiated an investigation into spp382 mutants’ ability to suppress
weak substrate mutations. I transformed spp382-1 and spp382-6 with reporter
plasmids (Rymond, Pikielny et al. 1990) which contain a RPS17A intron with
either a wild type branchpoint ( HZ18, UACUAAC), a strong branchpoint mutation
(UACUAAC Æ UACUACC, HZ10) or a weak branchpoint mutant (UACUAAC Æ
UCCUAAC, HZ3). The transformants were patched on dropout (minimal) plates
lacking uracil and the level of beta-galactosidase activity was checked by overlay
assay (see Materials and Methods). As seen in Figure 3.15, both spp382-1 and
spp382-6 suppress the weak branchpoint mutation as seen with increased beta
galactosidase activity (compare color intensity in HZ3 panel). No suppression is
seen with the stronger branchpoint mutation (HZ10) and neither do the mutants
appear to alter the use of the wild type substrate (HZ18).
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FIG 3.14. Genetic characterization of extragenic suppression. Yeast with ts
prp38-1, prp8-1 or prp4-1 mutations were transformed with a plasmid to
overexpress the mutant prp38-1 allele (GAL1::prp38-1) or the previously
characterized SPP381 dosage suppressor (GAL1::SPP381). The GAL1::spp3824 suppressor was expressed in the prp38-1, SPP382::KanR background. The
cultures were serially diluted and plated on yeast extract/peptone/galactose
medium at the restrictive temperature for prp8-1 (30°C) and prp38-1 (37°C). To
detect even minor changes in growth, a semi-permissive temperature of 30°C
was used for prp4-1.
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FIG.3.15. spp382 alleles suppress weak substrate mutants. Wild type or
spp382 mutant strains were transformed with the indicated RPS17a reporter
plasmid, grown on selective media for 3 days and then level of betagalactosidase activity was checked by overlay assay.
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Lowered Prp43p ATPase activity suppresses prp38-1 defect.
To investigate whether spp382 suppression is likely mediated via
decreased Prp43p activity, I directly tested mutant prp43 alleles for suppression
of the prp38-1 mutant. I obtained point mutants in the Prp43p DEAD/H box motif
or in the SAT box motif from the Schwer lab (Martin, Schneider et al. 2002).
These mutants differ in the level of residual ATPase activity. Among the three
mutants tested, the DEAD/H box mutant (prp43-H218A) has the lowest ATPase
activity (27%), while the SAT mutants (prp43-S247A and prp43-T249A) have
65% and 83% activity when compared to the wild type Prp43p activity (100%).
Each prp43 mutant was tested for suppression of the prp38-1 growth
defect at 36C. The double mutants were serially diluted and plated on YPD
plates at 36C. I found that each prp43 mutant suppressed the prp38-1 defect and
the degree of suppression was inversely proportional to the reported ATPase
activity (Fig 3.16). The mutant with the lowest ATPase activity (prp43-H218A)
suppresses better than the prp43-S247A mutant which in turn is more effective
than the weakest mutant, prp43-T249A.
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FIG 3.16. prp43 mutants also suppress prp38-1 defect. Three mutant alleles
of PRP43 assayed for growth at 36°C in the prp38-1 or wild-type (PRP38)
background. The Prp43p ATPase activities are from Martin et al (2002).
It should be noted that the figure is a composite of multiple plate cultures
incubated at the indicated temperatures for identical periods of time.
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A point mutant of Aar2p also suppresses the prp38-1 defect.
In order to identify the other strong recessive suppressor allele, I
transformed the suppressor strain (E4) with 133 genes (Listed in Table 1 in
Materials and Methods) that represent most of the known splicing factors as well
as other genes involved in RNA processing or function. Transformants were
selected by complementation of a plasmid-linked nutritional marker (URA3) at the
permissive temperature (23 °C) and then screened by streaking representative
colonies on nutrient rich media at 37 °C. One candidate gene (AAR2) was
recovered that blocked E4 suppression (Figure 3.18, lower panel). To confirm
that this was indeed a plasmid-linked event, the GAL1::AAR2 plasmid was retransformed into a naïve E4 suppressed strain. All the secondary transformants
assayed showed the reacquisition of the temperature sensitive phenotype,
demonstrating a plasmid-dependent event. Loss of plasmid by counter selection
through growth in the presence of the anti-metabolite, 5-fluroorotic acid, resulted
in colonies which were no longer ts (data not shown). Thus, Aar2p was most
likely to be the suppressor allele. Sequencing of the mutant aar2 locus revealed
a single nucleotide change (GÆA) that results in a single amino acid residue,
D281N. Based on this, I conclude that Aar2p is the other suppressor allele.
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FIG 3.17. aar2-D281N , a recessive point mutant, suppresses prp38-1.
Growth of wild-type yeast (PRP38 and AAR2), the prp38-1 mutant, and the
suppressed prp38-1, aar2-D281N double mutant assayed after 2 days at 37°C in
YPD. Overexpression of Aar2p inhibits growth of the double mutant (prp38-1,
aar2D281N) as shown in the lower panel. Both strains were assayed at 37 C on
YP-Gal after 2 days.
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Physical interactions of Spp382p with a DnaJ-motif protein, Cwc23p.
Spp382p has been reported in multiple complex particles recovered
from yeast cells such as the penta-snRNP (Stevens, Ryan et al. 2002), the U4,
U5, U6 snRNP spliceosomal complex (Wang, Hobbs et al. 2003) and other
complexes generally including Prp43p (Gavin, Bosche et al. 2002; Tsai, Fu et al.
2005). However, since each of these purifications was done at low salt
concentration, typically 100-150 mM NaCl, the complexity of the recovered multisubunit particles prevents assessment of likely primary binding partners of
Spp282p. To investigate high-affinity primary associations, I purified Spp382pTAP at greater stringency (i.e. 450mM NaCl) and assayed for interacting proteins
by mass spectroscopy. Cwc23p, a Dna J-like protein present in the spliceosome,
is the only splicing related protein recovered with high confidence in this
Spp382p-TAP complex (Table 3.2). The two ribosomal proteins and Rep2p (2
micron circle associated protein) were also identified and likely represent
contaminants of this preparation.
The mass spectroscopy results suggest interaction between Cwc23p
and Spp382p. To address this possibility by an independent methodology, I
assayed full-length copies of Spp382p and Cwc23p for two-hybrid interactions.
The yeast tester strain was grown for 3 days at 30 °C on plates lacking histidine
and supplemented with 20 mM 3-aminotriazole to score for activation of the
GAL4-regulated HIS3 gene. As seen in Figure 3.18, Spp382p and Cwc23p show
reciprocal positive interactions in this assay while neither binding partner auto-
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Table 3.2. Spp382-Cwc23 interaction. List of proteins co-purified with Spp382TAP identified by mass spectroscopy.
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FIG. 3.18. Physical interaction of Spp382p with the spliceosomal DnaJ-like
protein, Cwc23p. Serial dilutions of yeast stain PJ69-4a transformed with the
indicated plasmids spotted on plates lacking histidine and supplemented with 3
aminotriazole and grown at 30 °C for 3 days.
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stimulates the yeast reporter gene when paired with an empty vector control. The
two-hybrid results reinforce the interpretation of my proteomic data that the
Spp38p splicing factor interacts with the uncharacterized Cwc23p spliceosomeassociated protein.
Cwc23p was previously reported in splicing complexes purified with
Cef1p (Ohi, Link et al. 2002) and co-purifies with the Prp43p-DExD/H-box
ATPase (Gavin, Bosche et al. 2002) that acts with Spp382p to stimulate intron
release from the spliceosome in vitro. Chen and co-workers did not detect
Cwc23p associated with the Spp382p-Prp43p complex when assayed in vitro by
western blotting (Tsai, Fu et al. 2005).
At the time of my observation, no direct evidence existed to show that
Cwc23p actually plays an active role in the pre-mRNA splicing. In order to
investigate the cellular function of Cwc23p, I mutated conserved residues within
Cwc23p based on sequence alignment of the human, zebra fish, mouse, and
E.coli homologs (Figure 3.19) In addition to these selected sites, I also randomly
mutated the CWC23 open reading frame using the Genemorph Kit from
Stratagene. The plasmid-borne CWC23 gene was mutated and then transformed
into a yeast strain where the essential chromosomal copy of CWC23 was
replaced with the KANR gene (Winzeler, Shoemaker et al. 1999) and a URA3linked wild type CWC23 allele was present on a second plasmid. The activity of
the mutant allele was determined after removal of the URA3-linked wild type
copy by FOA selection. Yeast that failed to grow on FOA medium were
considered to have an inactivating mutation in the targeted CWC23 allele. Yeast
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viable after FOA selection were considered to possess only the putative mutant
copy of cwc23 and were scored for growth defects at 19 °C, 25 °C, 30 °C, and
37°C. All mutant alleles were sequenced to confirm the existence of DNA
changes.
The DNA J domain is an 80 amino acid motif (residues 15-95 in
Cwc23p) (Sahi and Craig 2007). Several of the mutants presented here reside
within this sequence (cwc23- 1, -2 and -4) or in the case with the more complex
mutants, at least one of the altered nucleotide lies within this domain (cwc233,5,6,7and 8). Mutations within the highly conserved HPD sub region of the
Cwc23p J-domain motif were found to impair growth (alleles cwc23-1 and cwc232) (Figure 3.19, residues 50-52 marked in yellow and Figure 3.20). Mutant
cwc23-3 showed wild type growth at 37 °C but was cold sensitive and grew much
less well at 30 °C or below (See Figure 3.20 and Table 3.2). A mutant in which
amino acids 80-84 are deleted (cwc23-4) and cwc23-6 (H65L, L136P, K147P)
were somewhat less severe but likewise showed growth defects at both the low
and high temperature. The cwc23-5 mutant with 3 amino acid substitutions
(L22F, L136P, K147R) grows slowly at all temperatures. Mutants cwc23-7 and
cwc23-8 were lethal. For all the complex changes (cwc23-3, 5, 6, 7, 8), it is
unclear whether it is changes in the J-domain or the mutations outside the Jdomain or a combination of mutations in both result in the growth impairment or
lethality.
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FIG 3.19. Alignment of the Cwc23p homologs across species. The
abbreviations used are, E.c – Escherichia coli (UniProt accession number
P08622), D.r – Danio rerio (UniProt accession number Q7ZUW0), H.s – Homo
sapiens (UniProt accession number Q96EY1), M.m- Mus musculis (UniProt
accession number Q99M87), S.c - Sacchromyces cereviciae(UniProt accession
number P52868).
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M.m.
57
H.s.
57
D.r.
60
E.c.
S.c.

1 ---MAAWCSPRWLRVAVGTPRLPAAAGRGVQQPQGGVVATSLCRKLCVSAFGLSMGAHGP

M.m.
117
H.s.
117
D.r.
115
E.c.
29
S.c.
46

58 RALLTLRPGVRLTGTKSFPFVCTTSFHTSASLAKDDYYQILGVPRNASQKDIKKAYYQLA

1 ---MAARCSTRWLLVVVGTPRLPAISGRGARPPREGVVGAWLSRKLSVPAFASSLTSCGP
1 MACSAARSSARWISAAVSSSHSRACSPFIPRADGAYRGFKSLSGRQMWTTRGGLSGGAGA
-----------------------------------------------------------------------------------------------------------------------

58 RALLTLRPGVSLTGTKHYPFICTASFHTSAPLAKEDYYQILGVPRNASQKEIKKAYYQLA
61 AVTLSG-----MTAIGSSHVVCKMSFHTSAPSRKQDFYQILGVPRSATQKEIKKAYYQMA
1 -------------------------------MAKQDYYEILGVSKTAEEREIRKAYKRLA
1 --------------MPGHELEDVINQRLNLYDVLELPTPLDVHTIYDDLPQIKRKYRTLA
:

M.m.
176
H.s.
176
D.r.
175
E.c.
84
S.c.
98

:*

118 KKYHPDTNKDDPKAKEKFSQLAEAYEVLSDEVKRKQYDAYGSAGFDPGASGS-QHSYWKG
116 KKYHPDTNKEDPQAKEKFAQLAEAYEVLSDEVKRKQYDTYGSAGFDAGRAGAGHQQYWGG
30 MKYHPDRNQGDKEAEAKFKEIKEAYEVLTDSQKRAAYDQYGHAAFEQGGMGG-----GGF
47 LKYHPDKHPDNPSIIHKFHLLSTATNILTNADVRPHYDRWLIEFLRKTNDIE-------: .

**

:

* : *::

*

** :

177 GPSVDPEELFRKIFGEFSSSP-FGDFQNVFDQPQEYIMELTFNQAAKGVNKEFTVNIMDT
177 GPTVDPEELFRKIFGEFSSSS-FGDFQTVFDQPQEYFMELTFNQAAKGVNKEFTVNIMDT
176 GTSIDPEELFRKIFGEFSGAQGFGDFNAIFNQPQEYVMELTFAQAAKGVNKEITVNIEGT
85 GGGADFSDIFGDVFGDIFGGG-RGRQRAARGADLRYNMELTLEEAVRGVTKEIRIPTLEE
99 ----RNKLIQKLEESESSTIPTTTPHPDLLQIQRHGELLRKLKHFNLPYGDWKHLNTQD..

M.m.
295
H.s.
295
D.r.
295
E.c.
203
S.c.
189

:*:: *

118 KKYHPDTNKDDPKAKEKFSQLAEAYEVLSDEVKRKQYDAYGSAGFDPGTSSS-GQGYWRG

: *** :
M.m.
235
H.s.
235
D.r.
235
E.c.
143
S.c.
153

.

:

236 CERCDGKGNEPGTKVQHCHYCGGSGMETINTGPFVMRSTCRRCGGRGSIITNPCVVCRGA
236 CERCNGKGNEPGTKVQHCHYCGGSGMETINTGPFVMRSTCRRCGGRGSIIISPCVVCRGA
236 CQRCDGRGHEPGSKVQHCGNCNGTGMETVNTGPFVMRSTCRRCGGRGSVITSPCIACRGT
144 CDVCHGSGAKPGTQPQTCPTCHGSGQVQMRQGFFAVQQTCPHCQGRGTLIKDPCNKCHGH
154 ---------QENASQHPYYDCSTLRIVLDNFLQSNNKSNCLSHLR---------------
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M.m.
346
H.s.
346
D.r.
346
E.c.
263
S.c.
211

296 GQAKQKKRVTIPVPAGVEDGQTVRMP---------VGKREIFVTFRVQKSPVFRRDGADI
296 GQAKQKKRVMIPVPAGVEDGQTVRMP---------VGKREIFITFRVQKSPVFRRDGADI
296 GQTKQRKTVTVPVPAGIEDGQTVRMP---------VGKKEIFITFKVQKSPIFRRDGADI
204 GRVERSKTLSVKIPAGVDTGDRIRLAGEGEAGEHGAPAGDLYVQVQVKQHPIFEREGNNL
190 --------------------------------------NQVFITLSANEIYDIYFSERNN
.: . .

M.m.
404
H.s.
404
D.r.
404
E.c.
321
S.c.
255

M.m.
H.s.
D.r.
E.c.
S.c.

:

347 HSDLFISIAQAILGGTAKAQGLYETIN-VTIPAGIQTDQKIRLTGKGIPRINS-YGYGDH
347 HSDLFISIAQALLGGTARAQGLYETIN-VTIPPGTQTDQKIRMGGKGIPRINS-YGYGDH
347 HSDVMISVAQAILGGTIRAQGLYETIN-LSIPVGTQTDQRIRLSGKGIPRVSG-YGYGDH
264 YCEVPINFAMAALGGEIEVPTLDGRVK-LKVPGETQTGKLFRMRGKGVKSVRG-GAQGDL
212 YSKDDSIIIYTVFDTPITAQHVFRNWS----------------SGNLIPTVKDISPLIPL
.

M.m.
462
H.s.
462
D.r.
453
E.c.
366
S.c.
283

:

.

:

.

:

*: :

405 YIHIKIRVPKRLSSRQQNLILSYAEDETDVEGTVNGVTHTSTGGRTMDSS--AGSKDRRE
405 YIHIKIRVPKRLTSRQQSLILSYAEDETDVEGTVNGVTLTSSGGSTMDSS--AGSKARRE
405 YVHIKIKIPKMLTDRQRALMMSYAEDESDVEGTVNGVTSTTAGKRSAGN----------322 LCRVVVETPVGLNERQKQLLQELQESFGGPTGEHNSPRSKSFFDG--------------256 HYYSDFNLETELNDDIARLVSNEPILLD-------------------------------.
.
463 AGEDNEGFLSKLKKIFTS 480
463 AGEDEEGFLSKLKKMFTS 480
-----------------367 ----VKKFFDDLTR---- 376
------------------
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FIG.3.20. Growth characteristics of cwc23 mutants. A. PCR-based
mutagenesis of CWC23. The panel shows the amino acid changes and
numbered coordinates on the 395 amino acid Cwc23 protein. B. Serial dilutions
of cwc23 mutants along with wild type yeast grown on YPD for 4 days at 25 °C
and 2 days at 37 °C. It should be noted that the figure B is a composite of
multiple plate cultures incubated at the indicated temperatures for identical
periods of time.
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Table 3.3. Growth phenotypes of cwc23 mutants.
The yeast cells were grown for 7 days at 19 °C, 4 days at 25 °C, 3 days at 30 °C
and 2 days at 37 °C.
Name

Change

Growth Phenotype @
19 °C 25

30

37

°C

°C

°C

Cwc23-1

HPD 50,51,52 ÆAAA

+/-

+/-

+

+

Cwc23-2

H50A

+/-

+/-

+

+

Cwc23-3

H50G,

+

++

+++

D52A,

R209G, +/-

S240G,K247R
Cwc23-4

H82, Y83, D84 deleted

+ +/-

+

+

+

Cwc23-5

L22F, L136P, K147R

+/-

+/-

+/-

+/-

Cwc23-6

H65L, L136P, K147P, E155X

++

++

++

++

Cwc23-7

V79A,L136P, K137X

Lethal

Cwc23-8

L22F, L136P, K147R, I204V, S239I

Lethal

CWC23

NA

+++
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Cwc23p is essential for normal cellular splicing.
Similar to what was shown above for GAL1::SPP382, incomplete
metabolic depletion prevents the use of regulated GAL1:: CWC23 to access the
role of the protein in cellular splicing (i.e., this strain continues to grow on
glucose-based medium; data not shown). Consequently, to investigate Cwc23p
function in pre-mRNA splicing, I conducted northern analysis using RNA
harvested from cells bearing the newly generated mutant alleles. To maximize
the chances of seeing an effect, I used conditions designed to stress the cells at
temperatures above or below the optimal growth temperature (of wild type yeast)
at 30 °C. Specifically, I assayed yeast after temperature shift from 30 °C to 19 °C
for 10 hours and after shift to 37 °C for 2 hours.
Splicing is impaired for both the J domain mutants (cwc23-1 and 2)
and for cwc23- 3 and cwc23-4 as the RPS17A pre-mRNA/mRNA ratio increases
relative to wild type yeast (Figure 3.21). I note that splicing is impaired for these
mutants even at temperatures where growth inhibition is not clearly seen. The
cwc23-5 mutant was clearly splicing impaired at 36 while no splicing defects
were obvious with cwc23-6 mutant. Minor differences in the levels of excised
actin intron were also observed although, in general, the elevated ACT1 intron
levels were more modest that what was observed with the spp382 mutants.
Primer extension analysis was performed to investigate whether premRNA or the similarly sized lariat intermediate accumulated after Cwc23p
inactivation (Figure 3.22). Reverse transcription extension with an end-labeled
RPS17A exon II oligonucleotide demonstrates primarily a step 1 block for
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FIG. 3.21. Cwc23p is essential for efficient cellular splicing. Northern
analysis of the non-lethal cwc23 alleles along with the wild type yeast and the
prp38-1 mutant assayed at 19 C (-) or after 2 hours at 37 °C (+). The lower panel
shows accumulation of the ACT1 excised intron RNA.
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FIG 3.22. cwc23 mutants show inhibition of the first transesterification
reaction in splicing. Primer extension analysis of RNA isolated from the
indicated cwc23 mutants and a wild type strain. Reverse transcription was
conducted with oligonucleotide complimentary to exon 2 of the RPS17a reporter.
The position of cDNA molecules corresponding to unspliced transcripts (premRNA ), spliced message (mRNA), lariat intermediate (lariat) and spliced
endogenous RPS17a message (asterisk) is indicated to the right.
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alleles tested (i.e., cwc23-1,-2, -3, and -4) indicating that the protein plays a role
in the first RNA cleavage ligation event in splicing. I cannot rule out a second role
later in splicing for the Cwc23p, however, since a strong block at the first
transesterification reaction would mask later defects in splicing.
Genetic interactions of CWC23
I note that Cwc23p is the only J-domain protein reported to date in
the spliceosome. The 80 amino acid J-domain motif was first defined in the E.
coli DnaJ protein, a Hsp40-like protein in which the J domain plays a role in
substrate presentation and or ATPase activation of an associated chaperone
(e.g., Hsp70) (Qiu, Shao et al. 2006). DNA J motif proteins are involved in the
assembly and disassembly events associated with a diverse set of multi-subunit
complexes (Walsh, Bursac et al. 2004). In this light, the previously stated
Spp382p- Cwc23p- Prp43p association is particularly intriguing as this defines
possible associations with DExD/H-box recruitment factor (Spp382p), an enzyme
(Prp43p) and possible regulator (Cwc23p). To explore this possibility, I
overexpressed CWC23 using the GAL1 promoter in wild type yeast and in prp43
mutant yeast with decreased Prp43p ATPase activity.
The prp43 mutants transformed with a negative control plasmid
(GAL1::CYC1) grow like the wild type strain on both glucose and galactose at 30
°C (figure 3.23). Overexpression of CWC23 does not impair growth of a wild type
strain either on glucose or galactose. While overexpression in the mutant, prp43H218A (27 % ATPase activity; (Martin, Schneider et al. 2002)), impairs cell
growth when grown on YP-galactose plates. This growth inhibition is reversed
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FIG. 3.23. Overexpression of Cwc23p exacerbates the growth of prp43
ATPase mutants. Prp43 mutants were transformed with a plasmid to over
express Cwc23p (GAL1::CWC23). The cultures were serially diluted and
separately plated on either YP-Gal or YP-Dextrose medium at the permissive
temperature for prp43 mutants (30°C).
It should be noted that the figure is a composite of multiple plate cultures
incubated at the indicated temperatures for identical periods of time.
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when the cells are grown on glucose. Overexpression of Cwc23p in the other
prp43 mutant, prp43- T249A (83 % ATPase activity; (Martin, Schneider et al.
2002), does not have any apparent effect on growth (Figure 3.23). This
observation indicates that excess Cwc23p impairs cell growth when Prp43p
ATPase activity is significantly reduced.
I showed above, within a certain range, reduced Spp382p activity or
reduced Prp43p activity suppresses prp38-1 and prp8 splicing mutants (Figure
3.14 and 3.16). I also scored all the cwc23 mutants for possible suppression of
the prp38-1 and prp8-2 associated growth defects. (Figure 3.24 A and C). None
of the cwc23 mutants suppress the prp38-1 growth inhibition at 36C or the prp8-1
or the prp8-2 temperature sensitivity at 30 °C. However, I do observe that prp8-2
suppresses the growth defect of the J domain cwc23 mutants at lower
temperatures (cwc23-1 and 2). While both cwc23-1 and cwc23-2 mutants grow
poorly at 19 °C, both strains grow better at this temperature when combined with
prp8-2. This suppression can be reversed when a wild type PRP8 is introduced
into the strain (Fig 3.24 B) indicating that improved growth of the cwc23 mutants
is due to the prp8 mutation. Thus, while providing genetic evidence for Cwc23p
interaction with the conserved Prp8p protein that believed part of the
spliceosome’s active site (Grainger and Beggs 2005), this experiment did not
reveal a suppressor phenotype for any of the cwc23 alleles generated so far.
Simultaneous transformation of the Cwc23p and Spp382p as Gal4 fusion
products lead to strong transactivation of the HIS3 in the yeast two hybrid
reporter strain, PJ694a. I tested whether the cwc23 mutants showed impaired
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FIG. 3.24. Genetic Interactions of Cwc23p. A. Serial dilutions of the double
mutants along with the parents were spotted on yeast extract/peptone/dextrose
medium and grown for 7 days in 19 °C or 3 days at 30 °C. B. Serial dilution of the
double mutants along with or without the wild type PRP8 grown on YPD at 19 °C
for 10 days. C. Serial dilutions of the cwc23, prp38-1double mutants along with
the parents spotted on YPD and grown for 3 days in 30 °C or for 2 days at 37 °C.
It should be noted that the figures are a composite of multiple plate cultures
incubated at the indicated temperatures for identical periods of time.
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FIG. 3.25. Two hybrid interactions of cwc23-1 and cwc23-2 with Spp382p.
The yeast strain, PJ69-4a, bearing the indicated plasmids indicated below, was
streaked on plates lacking histidine and supplemented with 3 aminotriazole and
grown at 30 °C for 3 days.
Panel A
1. pACT::Cwc23p + pAS2 –Spp382p
2. pACT::Cwc23p
3. pAS2 –Spp382p
4. pACT-cwc23-1p + pAS2 –Spp382p
5. pACT::cwc23-1p
6. Empty
Panel B
7. pACT::Cwc23p + pAS2 –Spp382p
8. pACT::Cwc23p
9. pAS2 –Spp382p
10. pACT-cwc23-2p + pAS2 –Spp382p
11. pACT::cwc23-2p
12. Empty
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interaction with Spp382p. I tested Spp382p two hybrid interaction with cwc23-1p
and cwc23-2p. For either mutant fused to the GAL4 activation domain (the pACT
constructs, Figure 3.25 panel A -4 and B-10), I fail to see any colonies, indicating
loss of interaction.

Overexpression of multiple different splicing factors inhibits
growth of the spp382-1, prp38-1 double mutant suppressor
strain.
I proposed that Spp382p mediates suppression due to impaired
dissociation of the spliceosome via Prp43p. Based on this model, any change
that enhances spliceosome turnover might be expected to counteract spp382-1based suppression. To identify possible effectors of spliceosome turnover, the
GAL1 promoter was used to overexpress 133 yeast genes (See Materials and
Methods), including most known splicing factors, in yeast in the original
“suppressor” strain (that is, bearing both the prp38-1 and spp382-1 mutations) on
rich medium containing galactose as sugar source, at 37 °C. While most genes
did not influence growth, PRP43, SPP382, CWC23, and orf YNL224c (that I call
SQS1 for squelch of splicing suppression) were among 14 genes found to impair
growth relative to the empty vector control transformant (Figure 3.26 A). The
remaining GAL1 effectors encode a variety of splicing factors (Bud13p, Bud31p,
Prp8p, Prp9p, Prp11p, Prp39p, Yhc1p), a protein involved in mRNA export and
turnover, Dhh1p, and, surprisingly, mitochondrial ribosomal proteins Yml6p and
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Mrp13p. The effect of overexpression on suppression was also checked at
permissive conditions for prp38-1 (i.e., 23 °C). Only MRP13 and SQS1
significantly impair growth of the suppressor strain at 23 °C on YP-galactose
(Figure 3.26 B).
The GAL1 promoter is transcriptionally induced 100 to 1000 fold by
galactose. To learn if the growth defects observed required such high levels of
induction, the transformants were assayed for growth on rich glucose-based
media at 23 C and 37 °C. None of the effector genes altered growth relative to
the control strain on YPD at 23 °C (data not shown). GAL1 repression on glucose
causes the GAL1::PRP9 and GAL1::MRP13 transformants to reacquire the
suppressed (i.e., better growth) phenotype (Fig. 3.26 A) at 37 C. This is not true
for most transformants, however, indicating that even a modest increase in
effector protein level reduces spp382-1 efficacy as a suppressor. Unexpectedly,
the GAL1::PRP43 and GAL1::BUD13 transformants appear more effective in this
assay when yeast are cultured on glucose. That is, the strains grow less well on
glucose-based medium than on the galactose-based medium.
To investigate whether the impaired growth observed with
overexpression required the double mutant (i.e., prp38-1, spp382-1) background
I checked the growth of the single mutant parental strains and in wild type yeast.
Other than the exceptions noted below, none of these genes significantly alter
growth of the spp382-1 or prp38-1 single mutants when assayed on rich medium
(Figure 3.26B). Overexpression of Prp43p-associated protein Ntr2p (Tsai, Fu et
al. 2005) relieves the modest ts defect of the spp382-1 single mutant (Figure
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3.27B). As expected, overexpression of PRP38 and SPP381 enhance growth of
the prp38-1 single mutant (Figure 3.27 B) with minor impact on the (prp38-1,
spp382-1) suppressor strain (Figure 3.26 B). SPP381 does not suppress the
prp38-1 defect when assayed on glucose medium, indicating that significantly
increased protein levels are needed to suppress this mutant strain ((Blanton,
Srinivasan et al. 1992; Xie, Beickman et al. 1998). None of these genes affect
the growth of wild type strain when assayed on rich medium.
YNL224C/SQS1 overexpression was reported to impair cell cycle
progression (Stevenson, Kennedy et al. 2001). Yet, we see no obvious growth
defect when this gene is expressed in wild type yeast on YP-galactose medium.
To investigate this obvious discrepancy, we reassayed growth of the
transformants on selective minimal media (lacking uracil and with galactose or
glucose as sugar source), the conditions used by the earlier group.
Overexpression of all constructs except SPP381 or PRP38 impairs growth of the
double mutant at 37. In addition, for PRP8, BUD31, MRP13, YML6, YHC1,
PRP39 and SPP382, the growth inhibition is reversed when grown on the dropout glucose medium (Figure 3.26 C). Overexpression of SQS1, DHH1, PRP8,
PRP43, BUD13, BUD31, YML6 and SPP382 also inhibit growth of the double
mutant at 23 °C in galactose while none of the constructs show impaired grown
on glucose at 23 °C.

126

FIG 3.26. Impact of overexpression under different conditions. A. Double
mutant (prp38-1, spp382-1) yeast cultures transformed with the indicated GAL1
fusion genes were serially diluted and spotted at 37 °C on medium to induce
(galactose) or repress (glucose) the GAL1 promoter.
B. The prp38-1, spp382-1 double mutant, wild type yeast (WT), the spp382-1
single mutant, and the prp38-1 single mutant strain transformed with either the
control (GAL1::CYC1) or the indicated GAL1 driven plasmids and assayed for
growth at permissive temperature (23 C or 35C) or restrictive temperatures in
YPGal or glucose based medium. The cultures were grown in parallel in the
same experiment as Fig A. The far end of permissive temperature (35C) was
selected for prp38-1 to increase the chance of observing minor exacerbations of
temperature sensitivity.
C. The prp38-1, spp382-1 double mutant and wild type yeast (WT), transformed
with either the GAL1::CYC1or the GAL1 driven constructs and assayed for
growth at permissive temperature (23 C) or restrictive temperatures in media
lacking uracil, with either galactose or glucose as the sole source for sugar. The
cultures were grown in parallel in the same experiment as Fig A.
It should be noted that the figures are a composite of multiple plate cultures
incubated at the indicated temperatures for identical periods of time.
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Unlike the case for rich medium, overexpression of SQS1, BUD31, DHH1,
and MRP13 also inhibits growth of the wild type yeast strain at 30°C and 37°C
when cultured on the defined medium. Overexpression of PRP8, CWC23, YML6
and SPP382 impairs growth of the wild type at 37°C. The growth inhibition in
these genetic backgrounds is reversed in all cases when the transformants are
grown in selective glucose medium. Based on this, I conclude that
overexpression of some splicing factors hypersensitizes the spp382 mediated
suppression and in some cases impairs growth of otherwise wild type yeast.
Finally, for all the constructs, I confirmed that transformants revert to the original
growth state after plasmid removal (data not shown).

Over expression of Sqs1p impairs cellular pre-mRNA splicing.
As noted above, overexpression of Sqs1p can impair growth of even
the wild type yeast. In addition, I note that like Spp382p, Sqs1p is a G-patch
protein (see figure 3.27) The increased sensitivity of the suppressed strain
(prp38-1, spp382-1) to Sqs1s overexpression and the fact that Sqs1p can be
affinity selected with complexes containing the Prp43p-DExD/H-box factor
(Gavin, Bosche et al. 2002), suggest possible involvement of Sqs1p in splicing.
To investigate this, I analyzed pre-mRNA splicing in wild type yeast grown in
drop out glucose media (lacking uracil) and various times after shift to galactose
(Figure 3.28 A) to induce GAL1::SQS1. While the pre-mRNA- message ratio
(indicator of splicing efficiency) is similar to control cells when grown in glucose,
the value increases as the time in galactose increases. Similar results were
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obtained when Sqs1p overexpression was assayed in the prp38-1 single mutant
or the suppressed double mutant prp38-1, spp382-1 (data not shown). The
control which lacks GAL1::SQS1 shows no inhibition of splicing when grown in
galactose media. Under this condition no change is seen with the intronless
ADE3 gene. While splicing is inhibited, over expression of Sqs1p does not affect
the stability of the splicing associated snRNAs. Northern analysis of the snRNAs
shows that while splicing is impaired, the snRNAs are not degraded (Figure 3.28
C).
The SQS1 gene is not essential for yeast viability (SGD database)
and I observe no growth defect in a sqs1::KAN knockout strain when grown at
RT or at 37 °C (Figure 3.30). While the overexpression results suggest splicing
involvement, northern analysis of RNA isolated from a sqs1::KAN null mutant
shows no obvious defect in splicing under normal (RT) or elevated temperature
(37 °C) (Figure 3.28 B). Thus, while overexpression of Sqs1p is cytotoxic and
inhibits splicing, the absence of this protein does not significantly impair premRNA splicing.
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FIG. 3.28. G-patch alignment of Spp382p and Sqs1p. Alignment of G-patch
motif with the consensus below. The sequences are named using the notation
Protein name _ Species abbreviation_Gene Bank GI (Gene identification
number). Abbreviations used Sc - Saccharomyces cerevisiae, Hs - Homo
sapiens, Sp -Schizosacchromyces pombe, Ca -Candida albicans, At Arabidopsis thaliana.

135

136

FIG.3.28 . Overexpression of Sqs1p impairs splicing. A. Northern analysis of
splicing inhibition with wild type yeast transformed with the nutritionally regulated
GAL1::SQS1 gene before and up to 9 hours after transcriptional induction by
galactose. Yeast that express a negative control vector (GAL1::CYC1) were
assayed in parallel after growth in glucose (T=0) or galactose (T-=9). The
positions of the intronless ADE3 mRNA and the RPS17A pre-mRNA and mRNA
are shown to the right.
B. Northern analysis of sqs1::KAN, a strain with chromosomal deletion of SQS1
along with a wild type strain and spp382- grown either at room temperature (-) or
at 37 °C (+).The positions of the intronless ADE3 mRNA and the RPS17A premRNA and mRNA are shown to the left
C. Northern analysis of the RNA from the overexpression experiment described
above (A) assayed for snRNA stability. The positions of snRNAs are indicated to
the right.
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Sqs1p interactions with Spp382p and related factors.
Three proteins, Spp382p, Cwc23p and Sqs1p were identified in this
study as having genetic or biochemical links to Prp43p. I investigated interactions
with this protein set by a directed two-hybrid study using full length proteins. As
shown before (Figure 3.18), Spp382p interacts with Cwc23p. Sqs1p was found to
interact with Spp382p but not with Cwc23p. Intriguingly, I could not generate a
double transformant of Sqs1p and Prp43p, indicating that simultaneous
expression of both factors as full length Gal4p fusion proteins is deleterious to
the cell. Consistent with previously published reports (Tsai, Fu et al. 2005),
Spp382p was observed to interact with the Prp43p DExD/H-box protein in the
two hybrid study. No interaction was detected between Cwc23p and Prp43p by
this assay (Figure 3.29).
As overexpression of Sqs1p impairs spp382p mediated suppression
of prp38-1, I tested if absence of SQS1 had any effect on growth of the prp38-1
mutant. SQS1::KAN neither suppressed nor exacerbated growth of the prp38-1
mutant (Figure 3.30).
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FIG 3.29. Two Hybrid interactions of Sqs1 with Spp382p and related factors.
Serial dilutions of the reporter yeast strain containing the indicated two hybrid
vectors was spotted on with medium lacking adenine (-Ade, glu) or lacking
histidine and supplemented with 20mM 3-aminotriazole (-His, glu +20 mM 3AT)
and grown at 30 °C for 3 days. It should be noted that the figure is a composite of
multiple plate cultures incubated at the indicated temperatures for identical
periods of time.
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FIG 3.30. Sqs1 null allele does not suppress prp38-1. Serial dilutions of the
indicated strains were spotted on the YPD plate and incubated at 25 °C for 4
days and 37 °C for 2 days.
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CHAPTER 4.
DISCUSSION
The spliceosome is a complex, dynamic ribonucleoprotein (RNP) complex
that undergoes numerous conformational changes during its assembly,
activation, catalysis and disassembly. Many of these conformational changes are
stimulated by the eight spliceosomal DExD/H box proteins at the expense of
ATP. While needed for the spliceosome cycle, surprisingly little is known of how
spliceosomal DExD/H proteins are recruited, the molecular details of target
association, what governs the temporal restriction of their enzymatic activities, or
even the primary targets of ATP-dependent function (e.g., RNA unwinding or
protein displacement). In contrast, the spliceosome assembly defects associated
with the loss of each activity is well documented. In their landmark studies on the
Prp16p DExD/H-box protein, Burgess and Guthrie proposed a model in which the
fidelity of correct branchpoint selection is coupled to ATP hydrolysis (Couto,
Tamm et al. 1987; Burgess, Couto et al. 1990; Burgess and Guthrie 1993). More
recently, Prp22p has been proposed to act in a similar manner during the 3’
splice site selection. Both results illustrate what might be considered a basic
gatekeeper feature of DExD/H-box ATPases in toggling alternative
conformational states. Here, the ATP hydrolysis by each of the DExD/H proteins
would drive the spliceosome cycle forward to the subsequent step and assure
fidelity in splicing when coupled with a discard pathway for the removal of flawed
complexes (Brow 2002; Query and Konarska 2004; Konarska and Query 2005).
Key to the underlying “kinetic proofreading” mechanism is the existence of a
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discard pathway to remove defective complexes. This discard pathway would
insure against faulty and potentially deleterious splicing events as well as
promote the recycling of limiting spliceosomal factors. While the components are
unknown, such a discard pathway has been speculated to act with DExD/H box
proteins throughout the spliceosome cycle as a quality control system for splicing
complex integrity (Konarska and Query 2005).
The underlying hypothesis of my research is that a spliceosomal discard
pathway exists in yeast and acts with the DExD/H box-proteins to promote
faithful splicing. My dissertation studies used a genetic approach to identify
putative components of this pathway and employed genetic, molecular, and
biochemical methodologies to investigate the contributions of the identified
factors to pre-mRNA splicing. This project was initiated with a genetic modifier
screen that isolated trans-acting suppressors of the prp38-1 mutant. Our
previous studies provided strong evidence that prp38-1 mutant yeast produced
complete but kinetically impaired spliceosomes (Blanton, Srinivasan et al. 1992;
Xie, Beickman et al. 1998). I proposed that the prp38-1 suppressors would likely
fall into two groups, 1) suppressors that improve splicing directly and 2)
suppressors that disable the discard pathway and thereby give more time for the
“slow” spliceosomes to work. Both predictions were supported by my
observations. For the first class, many intragenic suppressors were recovered.
These were noted but not chosen for further study since our primary interest was
in extragenic events.
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I propose that the mutation recovered within the uncharacterized open
reading frame, YLR424w, is characteristic of the second type of suppressor,
namely a suppressor that indirectly improves splicing through impairment of the
discard pathway. I have registered this gene with the Saccharomyces Genome
Database as SPP382, for the second suppressor of prp38-1 (that is suppressor
prp38-1 #2). The amino acid sequence of Spp382p provides little insight into its
function although this is clearly an evolutionarily conserved protein (Figure 3.2 )
that associates with components of the yeast and mammalian spliceosomes
(Gavin, Bosche et al. 2002; Hazbun, Malmstrom et al. 2003; Deckert, Hartmuth
et al. 2006; Collins, Kemmeren et al. 2007; Wang, Q., K. Hobbs, et al. 2003).
This protein does contain a G-patch motif, a ~ 48 amino acid motif containing six
highly conserved glycine residues, implicated in RNA binding. Other G-path
proteins in yeast include SPP2, PXR1, SQS1 and an unknown open reading
frame, YLR271w. Spp2p, like Spp382p, has been implicated in recruitment of a
DExD/H factor, Prp2p. Pxr1p is implicated in rRNA and snoRNA maturation and
the other two (Sqs1p and Ylr271w-p) are largely uncharacterized.
We previously observed the YLR424w –encoded protein as Ccf8p in a
proteomics study of the yeast spliceosome (Wang, Hobbs et al. 2003). This
earlier work used a late-acting splicing factor, Clf1p, in an affinity selection
scheme to identify subunits of the mature spliceosome. At least two distinct
multisubunit complexes were affinity purified with Clf1p, the mature or
postcatalytic spliceosome containing late-acting splicing factors and the U2, U5
and U6 snRNAs and the RNA-free Prp19-complex (NTC) that acts late in the
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assembly pathway and is released from the spliceosome after catalysis (Tsai,
Chow et al. 1999; Chen, Yu et al. 2002; Wang, Hobbs et al. 2003). Of the ~30
proteins characterized, Ccf8p was unique in that it was the only factor
preferentially enriched in the NTC fractions, prompting our suggestion that Ccf8p
may be an important factor in NTC-spliceosome dynamics (Wang Hobbs etc,
2003). As discussed below, I believe that the results of my studies and other
recent observations support this conclusion.
Though essential for cell survival, nothing was known about the cellular
role of Spp382p in splicing at the time of my investigation. To begin to address
this, I mutated conserved residues based on sequence homology. Mutating
conserved residues in the G-patch either results in cell death (spp382-9 or 10) or
impairs cell growth (spp382-2 or 3), indicating that this domain is essential for the
protein’s function. In general, mutations that affect growth also impair splicing
and accumulate precursor mRNA at restrictive temperature, indicating that this
protein is essential for the first transesterification reaction in vivo.
I found that extracts made from cells that were metabolically depleted of
Spp382p (spp382-4 grown in glucose) block spliceosome assembly prior to the
addition of the tri–snRNP, i.e. at the pre-spliceosome stage. While this suggests
a role in stable recruitment of the U4/U6.U5 tri-snRNP particle, we were not able
to efficiently complement this defect by exogenously added Spp38p, leaving
open the possibility that the initial Spp382p depletion resulted in the
destabilization or parallel depletion of other factors acting at this stage in splicing.
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Some of the mutants (spp382-1, -3, -5 and -6) also accumulate excess
amounts of the excised intron, as shown when probed with actin probe.
Accumulation of intronic RNA is seen with mutants that play a role in
spliceosome disassembly, like the 2’-5’ phosphodiesterase that linearizes the
lariat intron, Dbr1p, or the DExD/H protein involved in intron release and
spliceosome disassembly, Prp43p (Chapman and Boeke 1991; Arenas and
Abelson 1997), suggesting a role for spp382 in disassembly of the splicing
apparatus. Indeed it is quite possible to interpret the block in spliceosome
assembly seen with metabolically depleted extracts as indirect and resulting from
impaired recycling of splicing factors necessary for the first step of splicing.
Extracts prepared from yeast cells metabolically depleted of Spp382p by
transcriptional repression of a GAL1 fusion allele also showed little or no trisnRNP, increased amounts of the U4/U6 di-snRNP particle and what could be a
U2. U5.U6 snRNP (see band labeled * in figure 3.10). Based on total RNA pools,
spliceosomal snRNA stability does not appear to be reduced in cells
metabolically depleted for Spp382p as it is seen with the inactivation of certain
other splicing factors (e.g. Blanton et al., 1992). When the snRNP assembly is
monitored using native gels, the depleted extract shows an aberrant, slowly
moving complex above the tri-snRNP. A lesser amount of this complex can be
seen with functional extracts, consistent with the possible super-accumulation of
snRNP particles in a spliceosome like complex under Spp382p-limiting
conditions. In brief, my results show that Spp382p depletion in vivo does affect
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the tri- snRNP assembly, possibly because of impaired disassembly of the
spliceosome.
Chen and co-workers showed that Spp382p is necessary in vitro for intron
release from the mature spliceosome by the DExD/H helicase, Prp43p (Tsai, Fu
et al. 2005). While the mechanism is not known, Spp382p and Prp43p were
shown to interact by the two-hybrid method, supporting speculation that Prp43p
may act as a recruitment factor for Prp43p (Tsai, Fu et al. 2005). While my data
is consistent with such a model, I believe that other models may also explain
these results and the other published work. For instance, it is possible that
Spp382p acts more directly in Prp43p activation or substrate presentation.
The role of Prp43p in the dissociation of the late-stage spliceosome is
consistent with a similar activity in the proposed discard pathway. Since, at least
in vitro, Prp43p activity requires Spp382p, spp382 mediated suppression of
splicing factor mutations might reflect lowered Prp43p activity. Martin et. al.
showed that the ATPase activity was necessary for the Prp43p in vivo function
and a threshold activity of the protein was essential for viability (Martin,
Schneider et al. 2002). I tested the ability of three such viable prp43 mutants with
successively lower ATPases activities to suppress prp38-1. In keeping with my
assumption, I find that the prp43 mutants suppress the prp38-1 defect.
Importantly, the degree of suppression was inversely proportional to the residual
ATPase activity of the mutants characterized by Martin et. al. (Martin, Schneider
et al. 2002). This leads us to porpose a model in which defects in spliceosome
assembly, like those caused by prp38-1, prompt Spp382p-mediated disassembly

150

of the defective complex via Prp43p. In a simple model of splicing (Figure 4.1),
newly synthesized pre-mRNA is either spliced or degraded, with the splicing fate
favored under optimal conditions. We propose that under normal conditions,
conformational changes coincident with mRNA formation allow Spp382p to
stimulate Prp43p recruitment or activation and prompt intron release. When
splicing is slowed by a mutation, the splicing complex may be dissociated before
the completion of splicing and the pre-mRNA degraded or reassembled into a
new spliceosome. I propose that under conditions of limited Spp382p activity the
discard pathway slows and allows increased opportunity for splicing to occur with
kinetically impaired splicing mutants such as prp38-1.
One prediction of this model is that spp382 mutant suppression should not
be limited to prp38-1 but extend to other (although not necessarily all) mutations
in the splicing apparatus. Indeed, I found in addition to prp38-1(G66D), spp382
mutations suppress a second prp38 allele (C87Y) as well as mutations in prp8-2
and prp19-1. In addition, I recently obtained evidence that spp382-1 can partially
suppress a weak mutation in the pre-mRNA branchpoint region (UCCUAAC, HZ3
figure 3.16) and at the 3’ splice site showing that the suppression may extend to
substrate-level mutations and includes mutants defective in either
transesterification step in splicing (data not shown). Several other splicing factor
mutants that I assayed were not suppressed (prp4-1, rds3-1, prp39-1, prp16-1
and prp22-1). The reasons for lack of suppression are not known but might
include, for instance, the mutant forming a completely inactive spliceosome
which would fail to proceed to the next step.
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Defects in the splicing complex assembly such as those resulting from the
prp38-1 or prp8-1 mutations might allow for premature Spp382p association or
activation, resulting in spliceosome disassociation, likely via Prp43p. Consistent
with this, immune precipitation studies with a TAP-tagged Spp382p indicates that
this protein recovers an unusual defective splicing complex in which the 5’ exon
is dissociated. Such defective complexes are known to occur spontaneously in
vitro and we showed that the levels of defective complexes increase with
reduced 5’ exon length. Parker and colleagues have provided evidence that such
defective intermediates of splicing also form in vivo on natural substrates
(Hilleren and Parker; 2003). While clearly showing Spp382p association, at this
point we do not know whether exon loss promotes Spp382p binding or simply
exposes the TAP epitope on a complex where Spp382p was already present. In
addition, while it is clear that the TAP epitope on Spp382p does not significantly
inhibit splicing in vivo or in vitro, I cannot rule out a weak defect that might
contribute to formation of the 5’ exonless complexes that were recovered.
Intriguingly, while Spp382p binds spliceosomes that lack the upstream exon,
Prp8p interacts with this upstream exon before lariat formation (Teigelkamp,
Newman et al. 1995; Teigelkamp, Whittaker et al. 1995) and likely assists in its
retention afterward (see Grainger and Beggs 2005).
Several additional lines of evidence support the model of cooperative
Spp382p-Prp43p function in splicing. For instance, Spp382p and Prp43p interact
via two hybrid analysis (this study and Tsai, Fu et al. 2005). In addition, I found
that the prp43R424A mutation (Martin, Schneider et al. 2002) is synthetically
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lethal with spp382-4 and spp382-6 alleles consistent with an exacerbation of the
splicing defects. Also, I find that overexpression of Prp43p is sufficient to impair
the spp382-1 mediated suppression. One possible explanation for this last
observation could be that the elevated Prp43p levels compensate for possible
lower affinity mutant spp382-1 gene product (hence restoring the turnover activity
by mass action). Finally, our lab recently showed that partially purified Spp382pcomplex from yeast extracts, in vitro, dissociates the snRNP-complete
spliceosome in an ATP-dependant manner. In contrast, the U1/U2 containing
prespliceosome present in the same mixture is fully resistant to dissociation
(Rymond, unpublished). While at this point the assay is not selective for
“defective” spliceosome, the observations are consistent with Spp382p
association with late-stage splicing complexes and the stimulation of a turnover
activity.
The sedimentation profile of the released intron complex (Martin,
Schneider et al. 2002) is comparable to that of the nineteen complex (NTC)
fractions enriched with Spp382p (Wang, Hobbs et al. 2003), consistent with at
least transient association of Spp382p with late splicing complexes. The Cheng
lab showed that the affinity purified complex containing Spp382p (called NTR
complex containing Prp43p and Ntr2p along with Spp382p) is capable of
disassembling the spliceosome, separating the U2, U6 U5- NTC and the lariat
intron in vitro (Tsai, Fu et al. 2005). The Beggs lab recently confirmed that
presence of Spp382p is required for the Prp43p to bind to the post-catalytic
spliceosome (Boon, Auchynnikava, et al. 2006). Data from the Luhrmann lab
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suggest that, in vivo, the NTC binds the spliceosome before the activation of the
spliceosome and remains with the U5 snRNA after the completion of the catalytic
reactions and disassembly of the spliceosome (Makarov, Makarova et al. 2002).
Similar results have been observed in yeast (Tarn, Lee et al. 1993; Chan, Kao et
al. 2003). Although NTC factors act earlier in splicing as reported by our lab
(Wang, Hobbs et al. 2003). This 35S U5-NTC snRNP complex that exists after
splicing has to be disassembled, presumably also by Spp382p dependant
Prp43p activity. Indeed, we see a small amount of U5 snRNA with purified
Spp382-TAP (Figure 3.9 C). This is consistent with the presence of a U5 snRNA
containing post-spliceosomal complex (Makarov, Makarova et al. 2002). Prp8p, a
U5 snRNP protein, cross links to the 5’ splice site and is implicated in tethering
the 5’ exon for subsequent steps (Teigelkamp, Newman et al. 1995; Teigelkamp,
Whittaker et al. 1995; Grainger and Beggs 2005). Both Spp382p and Aar2p,
another U5 snRNP protein were recently found to be enriched in a complex
containing mutant version of Prp8p (Boon, Auchynnikava et al. 2006).
A mutant allele of aar2, aar2-D281N, was also recovered as a suppressor
of prp38-1. Aar2p is a component of the 16S U5 snRNP along with Prp8p,
Snu114p and core Sm proteins. The 16S U5 snRNP co-purifies with U1 snRNP
and this disnRNP particle has been implicated in 5’ splice site recognition
(Gottschalk, Kastner et al. 2001), suggesting an early co-operative role for U5
snRNP in the spliceosome assembly, particularly the 5’SS selection. Aar2p, also
is required for the recycling of splicing factors. Splicing proceeds normally with
depletion of Aar2p in vitro, unless “multiple turnover” of the spliceosome is
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required. Under these conditions, extracts depleted of Aar2p fail to splice,
indicating that Aar2p is necessary when splicing depends on snRNP recycling
(Gottschalk, Kastner et al. 2001). Splicing factors are recycled to sustain multiple
rounds of catalysis required for the processing of the abundant intron-bearing
pre-mRNAs. Hence sequestering factors in dead end spliceosomes has dire
effects on growth. We speculate that lowering but not abolishing the activity of a
spliceosome recycling factor allows stalled but partially active spliceosomes
additional time to splice. The published data are consistent with such a function
for Aar2p but it is unclear for now whether Aar2p acts via Prp43p- mediated
disassembly of defective spliceosomes.
The overexpression of several genes was found to reverse the salutary
effects of diminished Spp382p activity on splicing mutants. While proteins linked
by genetics or proteomics to Spp382p or Prp43p (i.e., Cwc23p, Sqs1p) likely
enhance the recruitment or function of the proposed dissociation complex, it is
unclear how the remaining effector genes act. In principle, any condition that
enhances spliceosome disassembly should reduce spp382-1 effectiveness in the
prp38-1 suppression assay. One can imagine, for instance, that excess levels of
an early acting splicing factor (e.g., Prp39p (U1 snRNP), or Prp9p (U2 snRNP))
might prompt dissociation of a late-acting factor through competition for a
common protein or RNA binding site. On the other hand, a protein like Dhh1p
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FIG 4.1. Model of spliceosome integrity (SPIN) surveillance and intron
release. The model proposes that Spp382p serves a role both in the release of
correctly spliced intron and in the dissociation of defective spliceosomes. Under
normal conditions, Spp382p binds (or is exposed on) the spliceosome
concomitant with the changes bought about by the mRNA being release. This
event precipitates Prp43p recruitment and intron release. When splicing is
slowed by a mutation (e.g. prp38-1, prp8-1, or loss of 5’ exon), this allows for
premature Spp382p association (or exposure), resulting in spliceosome
disassociation via Prp43p. By extension, decreased Spp382p or Prp43p activity
is likely to extend the spliceosome stability and therefore the likelihood of
processing by a partially active complex. Here, the oval bearing the question
mark represents a factor that normally restricts Spp382p binding (or access) until
completion of splicing or complex distortion by mutation.
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may act via a completely different mechanism through premature pre-RNA
nuclear export or decay (Coller and Parker 2005)
The spp382-1 mutation resides within the proposed Ntr2p binding site
region defined by two hybrid analysis (Uetz, Giot et al. 2000; Ito, Chiba et al.
2001; Chan, Kao et al. 2003). Here, it is possible that overexpression of Ntr2p
compensates for a weakened interaction between the two proteins to enhance
spp382-1p activity on the prp38-1 background. This also would explain how
overexpression of Ntr2 also suppresses the modest spp382-1 growth defect.
While challenging, elucidation of the various spp382-1 suppression blocking
activities acting through gene overexpression may provide insight into the
processes that influence spliceosome homeostasis. Recently, our lab looked at
the effect of the overexpression of these proteins had on splicing in the wild type
strain (data not shown). We found that overexpression of Prp8p, Sqs1p, Cwc23p
and Spp382p impair splicing while overexpression of other factors did not impact
splicing, at least for the RPS17a gene. However, we looked at only one time
point after galactose induction (6 hours), which may have been insufficient to see
the effect with the rest of the proteins.
Just as seen with Prp43p overexpression, two other proteins that co-purify
with Prp43p (Sqs1p/Ynl224c-p, a G patch protein and Cwc23p, a Dna J like
protein) also inhibit the growth of the spp382-1, prp38-1 double mutant
suppressed strain when overexpressed. It should be noted that neither one of
these genes significantly alter growth of wildtype yeast or the spp382-1 or prp381 single mutants when grown on YP-galactose plates. SQS1 overexpression has
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been reported to impair cell cycle progression (Stevenson, Kennedy et al. 2001)
and thus impair growth. I confirmed this observation when the assay was done
on defined medium. Although, Sqs1p is not essential for either robust growth or
splicing, I do find that overexpression of Sqs1p impairs both splicing and growth
even in wild type strain. Sqs1p may increase the efficiency of splicing as many
other non-essential splicing factors do (e.g. Mud2p association helps binding of
the branchpoint binding protein). Hence it would not be required for splicing per
se but overexpression might tie up binding partners essential for splicing and
hence impair their normal function. For some inexplicable reason, we do see a
difference in the rich vs. selective media.
Sqs1p, like the Prp43p activator, Spp382p and the Prp2p activator,
Spp2p, is a G-patch protein. This observation raises the interesting question of
whether Sqs1p might play a role similar to Spp382p in the recruitment or
activation of DExD/H box proteins. The splicing defects when overexpressed
along with two hybrid interaction with Spp382p suggest that it could do so.
However, alternate models of Sqs1p function are possible- Sqs1p over
expression might affect splicing indirectly (by inhibiting transcription of core
splicing factors) or perhaps the “G-patch” of Sqs1p binds with lower affinity core
splicing factors normally recruited via similar “G-patch” protein and renders them
non-functional when present in excess amounts.
My proteomic study shows that Cwc23p co-purifies with Spp382p under
high stringency, an interaction I confirmed by two hybrid analysis. Cwc23p, like
Spp382p, is an essential protein whose role in splicing was not characterized
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prior to this study. Mutational analysis of this protein shows that its J domain is
important for function. My results demonstrate that Cwc23p mutants show
impaired splicing and growth. Previous studies with DnaJ proteins in E.coli
(Hsp40) and in yeast (Ydj1) (Wall, Zylicz et al. 1994; Wall, Zylicz et al. 1995;
Becker, Walter et al. 1996; Yan and Craig 1999) show that mutations in the Jdomain are either lethal or impair the activity of their Hsp70 partners. In addition,
in vitro biochemical studies show that the J domain alone is sufficient to stimulate
the ATPase activity of the Hsp70p similar to that observed with full length DnaJ
protein (Wall, Zylicz et al. 1994). My results show that the DnaJ domain is also
important for Cwc23p function and by extrapolation to the published studies, may
play a role in regulating an ATPase in the spliceosome. This would be exciting
because Cwc23p is the only known J domain protein in the spliceosome. Since,
Cwc23p is found in proteomic complexes pulled down using Prp43-TAP (Gavin,
Bosche et al. 2002; Tsai, Fu et al. 2005) or Spp382-TAP (this study) as bait, it is
possible that Cwc23p modulates the Prp43 DExD/H -box protein.
Primer extension analysis of mRNA isolated from several cwc23 mutants
reveals an inhibition of the first transesterification step in splicing when Cwc23p
is inactivated. In addition some Cwc23p mutants also accumulate excess excised
intron, like Spp382p or Prp43p, suggesting that this protein may play a role in
recycling of splicing factors. I observed that the cwc23 J-domain mutants fail to
interact with the Prp43p binding partner Spp382p in the two hybrid assay.
Although I find no evidence for Prp43p-Cwc23p interaction by two hybrid assay,
over expression of Cwc23p in the prp43-H218A strain impairs cell growth. This
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suggests that at least under the conditions tested, too much Cwc23p may
dampen Prp34p activity. While I found no cases of suppression of other splicing
mutants by the cwc23 mutants, I found that the prp8-2 mutation suppressed the
growth impairment of the J domain mutants, cwc23-1 and cwc23-2. Recently
other prp8 mutant alleles have been shown to suppress either the first step or
second step splicing defects. The interpretation of the results from many genetic
experiments is that Prp8p has a role in repositioning the pre-mRNA during the
transition between the two catalytic steps of splicing (Liu, Query et al. 2007). In
this light, prp8 mutant could be relieving the cwc23 -1 and cwc23-2 blocked
spliceosome.
In addition to its role in splicing, Prp43p plays a critical role in the rRNA
processing, and is required for production of both the small and the large subunit
rRNAs. Prp43p can be recovered with the 35S rRNA precursors and all the
subsequent intermediates (Lebaron, Froment et al. 2005). It is also present in the
very early pre -60S pre-ribosomal particles. prp43 cold sensitive mutants show
increased 35S pre-rRNA and depleted levels of 20S, 27S and 7S pre-rRNA
precursors (Lebaron, Froment et al. 2005; Combs, Nagel et al. 2006; Leeds,
Small et al. 2006). At the steady state, most Prp43p is found in the nucleolus, the
site of rRNA biogenesis (Huh, Falvo et al. 2003). Since Prp43p plays a dual role
in splicing and rRNA biogenesis, it is interesting to speculate on how the protein
is functionally and physically partitioned. One clue arises from the observation
that, in addition to binding the Spp382p splicing factor Prp43p interacts with
Pxr1p, a second G-patch protein required for rRNA biogenesis. Our lab has
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examined rRNA biogenesis in the spp382 mutant background and could find no
evidence for this protein acting in the rRNA pathway (data not shown), consistent
with a specific role in splicing. Conceivably, the alternative G-patch proteins,
Spp382p and Prx1p, bind Prp43p in a mutually exclusive fashion to direct the
location and activity of Prp43p. This model is currently under investigation (see
figure 4.2).

162

FIG. 4.2. Prp43p – Role in spliceosome and ribosome biogenesis. A
schematic representation of (A) the Prp43p-Spp382p mediated steps (indicated
with the pink circle) in splicing occurring in the nucleus. The * refers to
conclusions based on the results of this study. (B) shows Prp43p dependant
steps in rRNA biogenesis (orange circle) in the nucleolus.

163

164

Future DirectionsThe results presented here provide strong evidence for a Spp382dependant spliceosome integrity (SPIN) complex acting in the discard pathway.
While our data suggests that the SPIN complex acts to disassemble the
spliceosome possibly at several stages (Prp38p, Prp8p or Prp19p dependant
step), it is unclear how the complex recognizes defective substrates and what
other components make up the SPIN surveillance complex. Based on the
available genetic and biochemical data, we suspect that Spp382p interactions
with Prp43p, Cwc23p, Ntr2p and perhaps Sqs1p may contribute to SPIN activity.
However, it remains to be investigated if there are other proteins that also work
with Prp43p-Spp382p at this surveillance function. Moreover, the role that
Cwc23p and Sqs1p play in this complex remains to be understood.
How the cells target the defective complex and how the surveillance
complex is kept in check to avoid inappropriate turnover of active spliceosome
also remains to be addressed. Since the cell regulates protein activity by
chemical modification (eg. phosphorylation, acetylation, ubiquitination etc), it
would be interesting to see whether proteins involved in the SPIN complex are
present with such modifying groups in vivo. It remains to be investigated whether
SPIN surveillance, the turnover of postcatalytic spliceosomes, and Prp43p
function in ribosome biogenesis (Lebaron, Froment et al. 2005; Combs, Nagel et
al. 2006) are accomplished by entities of identical or overlapping protein
compositions. Since Prp43p interacts with two G-patch proteins, Spp382p (which
is essential for splicing) and Pxr1p (involved in rRNA biogenesis), it is interesting
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to speculate whether these two G-patch proteins are responsible for partitioning
Prp43p between the two separate complexes. Since both Spp2 and Spp382p,
are now believed to be involved in recruiting the DExD/H box proteins to the
spliceosome, it will be important to learn how substrate selection is determined
by these and the other known yeast G-patch proteins (Pxr1p, Sqs1 and
Ylr271w-p).
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Appendix 1.
Spp381p – Prp38p –Snu23p form a stable heterotrimeric complex.
Prp38p is a small (28 kDa), highly acidic tri-snRNP specific protein that is
required for spliceosome maturation (Blanton, Srinivasan et al. 1992);(Xie,
Beickman et al. 1998). Prp38p mutants fail to unwind U4/U6 helices, an
important step for activation of spliceosomes. Prp38p is unlikely to be a helicase
(based on absence of canonical helicase motifs) but it may act to recruit or
activate one. The Prp38p mediated release of the U4 snRNA is not well
understood.
To begin our study of Prp38p function, we wanted to investigate what this
protein binds in vivo. We metabolically labeled yeast with 35S-methionine and
cysteine and purified proteins from a Prp38-TAP strain and an untagged control.
Purification with Prp38p-TAP pulled showed a heterotrimeric complex. The
Prp38p protein is associated with two proteins, Spp381p, previously identified as
a dosage suppressor of prp38-1, (Lybarger, Beickman et al. 1999) and a small
protein, the same molecular weight as previously identified Snu23p, a tri-snRNP
protein. To see whether this assignment is true, I purified the complex using
Prp38-TAP, Spp381-TAP, and Snu23-TAP tagged strains. All three strains
recover the same three proteins (i.e., Prp38p, Prp381p, Snu23p), as indicated by
band shifts. The asterix indicates the position of proteins with a residual TAP tag.
To avoid recovery of complex spliceosomes, two step TAP selection was
performed at 450 mM NaCl. The proteins were resolved on a polyacrylamide gel
and, where possible, the tentative protein assignments (based on observed sizes
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and previous studies) were confirmed by western analysis by using the anti-CBP
and the anti-Prp38p antibody (data not shown).
Consistent with the affinity purification results, the three proteins also
interact by two hybrid assay as shown in table A1.1.
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FIG A1. Prp38p-Spp381p-Snu23p form stable heterotrimeric complex. 35Slabeled proteins from Spp382-TAP, Prp38-TAP, Spp381-TAP or an untagged
yeast strain were isolated by two step TAP selection at 450 mM NaCl and
resolved on a polyacrylamide gel. The protein assignments were confirmed by
western analysis. The CBP indicates the residual tag that remains after TEV
cleavage.
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Table A1.1. Two hybrid interactions. The yeast strain PJ69-4a, was cotransformed with the indicated Gal4p fusion products and growth assayed on
medium lacking histidine and supplemented with 3 aminotriazole.

pACT

pAS2

Interaction

Prp38

Spp381

Yes

Prp38

Snu23

Yes

Snu23

Spp381

Yes

Spp381

Snu23

Yes
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